Postexercise Hypotension (PEH) in the Dog: Possible Role of Immune System Cytokines. by Thompson, Gerald Dwayne
Louisiana State University
LSU Digital Commons
LSU Historical Dissertations and Theses Graduate School
1996
Postexercise Hypotension (PEH) in the Dog:
Possible Role of Immune System Cytokines.
Gerald Dwayne Thompson
Louisiana State University and Agricultural & Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact
gradetd@lsu.edu.
Recommended Citation
Thompson, Gerald Dwayne, "Postexercise Hypotension (PEH) in the Dog: Possible Role of Immune System Cytokines." (1996). LSU
Historical Dissertations and Theses. 6285.
https://digitalcommons.lsu.edu/gradschool_disstheses/6285
INFORMATION TO USERS
This manuscript has been reproduced from the microfilm master. UMI 
films the text directly from the original or copy submitted. Thus, some 
thesis and dissertation copies are in typewriter face, while others may be 
from any type of computer printer.
The quality of this reproduction is dependent upon the quality of the 
copy submitted. Broken or indistinct print, colored or poor quality 
illustrations and photographs, print bleedthrough, substandard margins, 
and improper alignment can adversely afreet reproduction.
In the unlikely event that the author did not send UMI a complete 
manuscript and there are missing pages, these will be noted. Also, if 
unauthorized copyright material had to be removed, a note will indicate 
the deletion.
Oversize materials (e.g., maps, drawings, charts) are reproduced by 
sectioning the original, beginning at the upper left-hand comer and 
continuing from left to right in equal sections with small overlaps. Each 
original is also photographed in one exposure and is included in reduced 
form at the back of the book.
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6” x 9” black and white 
photographic prints are available for any photographs or illustrations 
appearing in this copy for an additional charge. Contact UMI directly to 
order.
UMI
A Bell & Howell Information Company 
300 North Zeeb Road, Ann Arbor MI 48106-1346 USA 
313/761-4700 800/521-0600
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
POSTEXERCISE HYPOTENSION (PEH) IN THE DOG: 
POSSIBLE ROLE OF IMMUNE SYSTEM CYTOKINES
A Dissertation
Submitted to the Graduate Faculty of the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment of the 
requirements for the degree of 
Doctor of Philosophy
in
The Department of Kinesiology
by
Gerald D. Thompson 
B.S., University of Southwestern Louisiana/ 1988 
M.Ed./ University of New Orleans/ 1989 
August 1996
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
UMI Number: 9706368
UMI Microform 9706368 
Copyright 1996, by UMI Company. All rights reserved.
This microform edition is protected against unauthorized 
copying under Title 17, United States Code.
UMI
300 North Zeeb Road 
Ann Arbor, MI 48103
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
DOCTORAL EXAMINATION AND DISSERTATION REPORT
Candidate: Gerald D. lhonpsor.
Major Field: Kinesiology
Title of Dissertation: Fostexercise Hypotension (PEK) in the Dog
Possible Role of Immune System Cytokines
Approved:
Major Professor id Chairman




June 1 ~ , 1996
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ACKNOWLEDGEMENTS
This dissertation project is the culmination of years 
of study, hard work, and sacrifice. I owe a debt of thanks 
and gratitude to all who have taught, supported, and 
encouraged me in my academic endeavors. Thanks are given to 
my committee members, Dr. B. Don Franks, Dr. David B. West, 
Dr. Arnold Nelson, Dr. G. Stephen Morris, Dr. David Horohov, 
and Dr. Evangelos Triantaphyllou. Special thanks are given 
to my co-chairs, Dr. B. Don Franks whose patiences, wisdom 
and friendship I will always remember, and Dr. David B. West 
whose intelligence, day-to-day guidance, and American can-do 
spirit I have and will always benefit from both 
professionally and personally. Although not a formal member 
of my committee, I would also like to thank Dr. Vernon Bond 
for his friendship and encouragement for I think he exhibits 
an intellectual tenacity that distinguishes him as a true 
scientist.
Many others have contributed to my academic pursuits. 
Thanks to Dr. David Horohov amd Dr. Daniel Hwang for the use 
of their laboratories for the development of my immune system 
cytokine and prostaglandin assays, respectively. I would 
also like to thank Dr. Richard Tulley and his staff in the 
clinical laboratory, Dr. James Delany and his body 
composition staff, and Liz Tucker and the clinical trials 
staff at Pennington Biomedical Research Center for their help 
with work done in my dissertation program.
ii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
I would like to thank the National Institutes of Health 
(NIH) for the pre-doctoral minority supplement which was 
awarded to me. In so doing, NIH has allowed me to pursue 
research opportunities that I would not have gotten 
otherwise. Because this is an affirmative action program, 
and affirmative action programs are the topic of heated 
discussions and much political debate in America today, I 
would like to mention something about this issue. When 
instituted correctly, affirmative action programs not only 
serve to benefit women, Native-Americans, Hispanic-Americans, 
Oriental-Americans, Pacific Islanders and African-Americans
but they also benefit people who know that the future success 
of America is directly related to the quality of life of all 
Americans.
I am also personally thankful to the secretaries within 
the Department of Kinesiology at LSU, Shelly Arnold, Sherry 
Johnson, Marie Bernard, and Sheila Hart for their unhesitated 
assistance. Thanks are also given to Alycia Truett whose 
daily help and encouragement made life and my work a lot 
easier. For their support and companionship along the way, I 
would like to thank my fellow Ph.D. students, Chris Hearon, 
Barry Cohen, Mike Prevost, Debie Hastings, Sherri Savoie, 
Martha Amaral-Melendez, Louis Harrison, Jr., and Dr. Agatha 
Borne.
Lastly, I would be remiss if I were not to have 
mentioned and thanked my family. Thanks are given to my 
mother and father who loved me, to my brothers and sister who
iii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
supported me, to my aunts and uncles, especially my Aunt 
Geraldine Doucet, who were my visible role models. To my 
wife, Melissa T. Thompson and children, Jamaal G. Thompson 
and Aysha J. Thompson who have given me a reason to live, 
love, and learn, I am very grateful. Indeed, I heard once 
that having a Ph.D. does not mean that you are smarter than 
others who do not, rather it simply means that you were able 
to stay in school longer. Thanks Melissa, for providing me 
the time to pursue my doctoral studies. To my grandmother, 
Alta C. Doucet goes all the glory. Knowing that you allowed 
yourself to be cold in my shadow, so that I might have my day 
in the sun, I thank you from the depths of my soul with much 
respect and with all my love. Thank God for his grace, and 
for his love to be manifested through my grandmother. She is
as deserving as any hollywood celebrity or public servant to
receive an honorary Ph.D. It is because of my grandmother, 
having not one-day of formal education, and her significant
contribution to my life that I present to her my doctor of
philosophy degree.
iv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
TABLE OF CONTENTS
ACKNOWLEDGEMENTS ...................................  ii
LIST OF TABLES .....................................  vii
LIST OF FIGURES ....................................  viii
ABSTRACT...........................................  x
CHAPTER
1 INTRODUCTION .............................  1
Project Rationale ...................  4
Problem Statement...................  5
Hypothesis ..........................  5
Limitations .........................  6
2 REVIEW OF LITERATURE .....................  7
Exercise in the D o g .................  7
Postexercise Hypotension (PEH) ......  9
Interleukin-1 (IL-1) ................  15
Hypotension....................  17
Exercise .......................  19
Summary .............................  21
3 METHODS AND PROCEDURES ...................  23
Animal Care and Preparation.........  23
Animals ........................  23
Surgical Implantation..........  24
Exercise Habituation...........  25
Maximal Exercise Testing ............  25
Baseline .......................  25
Exercise .......................  26
Postexercise ...................  27
Submaximal Exercise Testing .........  27
Experiment I ...................  27
Baseline .......................  28
Exercise .......................  29
Postexercise ...................  29
Experiment II ..................  29
Baseline .......................  30
Ibuprofen Infusion .............  30
Dexamethasone Infusion .........  31
Postinfusion ...................  31
Experiment III .................  31
Experiment A ..............  32
Experiment B ..............  33
Analysis of Data ....................  36
Blood Pressure and Heart Rate ... 36
Posture Effects ................  37
Plasma and Serum...............  37
v
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Prostaglandin E2 ................. 37
Bioassay of IL-1.................  39
Statistics ..................... 40
4 RESULTS ................................... 41
Experiment I ........................  41
Experiment II .......................  48
Experiment IIIA.....................  51
Experiment IIIB......................  57
Dexamethasone Treatment Across
Days.......................  58
Exercise 1 Following Dexamethasone
Treatment vs. Saline Control 59
Exercise 1 vs. Exercise 2 .......  60
Posture Effects of All Experiments ... 61
5 DISCUSSION................................ 75
Experiment I ........................  75
Experiment II .......................  80
Experiment IIIA.....................  83
Experiment IIIB......................  86
Dexamethasone Treatment Across
Days ......................  87
Exercise 1 Following Dexametha­
sone Treatment vs. Saline
Control ...................  90
Posture Effects of All Experiments ... 93
6 SUMMARY AND CONCLUSIONS ................... 95
REFERENCES ..................................... 97
V I T A ...........................................  110
vi
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF TABLES
1. Exercise paradigms utilized in past studies.....  10
2. Protocol for maximal exercise testing in the dog . 27
vii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF FIGURES
Figure 4.1. Baseline (BL) and Postexercise Heart Rate (HR)
Response to 85% HRmav Exercise for 30 Minutes 
and 60% HRmax Exercise for 60 Minutes.......... 43
Figure 4.2. Baseline (BL) and Postexercise Systolic Blood 
Pressure (SBP) Response to 85% HRmay Exercise 
for 30 Minutes and 60% HRmav Exercise for 60 
Minutes .......................................  44
Figure 4.3 Baseline (BL) and Postexercise Mean Arterial 
BloodPressure (MABP) Response to 85% HRmay Exercise 
for 30 Minutes and 60% HRmav for 60 Minutes ... 45
Figure 4.4. Analysis of Prostaglandin E2 (PGE2 ) ... 46
Figure 4.5. First Analysis of Interleukin-1 (IL-1) 47
Figure 4.6. Baseline (BL) and Postinfusion Heart Rate (HR) 
Response for Nonexercised Controlled Infusions 
of Ibuprofen or Dexamethasone...............  49
Figure 4.7. Baseline (BL) and Postinfusion Prostaglandin 
(PGE2 ) Response for Nonexercised Controlled Infusions 
of Ibuprofen or Dexamethasone ................ 50
Figure 4.8. Ibuprofen (IB) vs. Saline (NaCl) Control Heart 
Rate (HR) Responses ..........................  52
Figure 4.9. Ibuprofen (IB) vs. Saline (NaCl) Control 
Systolic Blood Pressure (SBP) Responses....... 53
Figure 4.10. Ibuprofen (IB) vs. Saline (NaCl) Control Mean 
Arterial Blood Pressure (MABP) Responses ..... 54
Figure 4.11. Ibuprofen (IB) vs. Saline (NaCl) Control 
Diastolic Blood Pressure (DBP) Responses...... 55
Figure 4.12. Ibuprofen (IB) vs. Saline (NaCL) Control Plasma 
Prostaglandin E2 (PGE2) Responses ............. 56
Figure 4.13. 24-hour Heart Rate (HR) .............  62
Figure 4.14. 24-hour Systolic (SBP), Diastolic (DBP), and 
Mean Arterial Blood Pressures (MABP) ......... 63
Figure 4.15. Baseline (BL) Prostaglandin E2 (PGE2 ),
Dexamethasone Treatment Across a 4-day Period, 
and on Days of Exercise (Ex) ................. 64
Figure 4.16. Heart Rate (HR) Responses to Exercise Following 
Dexamethasone (Dex) or Saline (NaCl) Treatment 65
viii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 4.17. Systolic Blood Pressure (SBP) Responses to 
Exercise Following Dexamethasone (Dex) or Saline 
(NaCL) Treatment ............................  66
Figure 4.18. Diastolic Blood Pressure (DBP) Responses to 
Exercise Following Dexamethasone (Dex) or Saline 
(NaCl) Treatment ............................  67
Figure 4.19. Mean Arterial Blood Pressure (MABP) Responses to 
Exercise Following Dexamethasone (Dex) or Saline 
(NaCl) Treatment ............................  68
Figure 4.20. Prostaglandin E2 (PGE2 ) Responses to Exercise 
Following Dexamethasone (Dex) and Saline (NaCl)
Treatment ...................................  69
Figure 4.21. Heart Rate (HR) Responses to Two Exercise Bouts
Following Dexmethasone Treatment ............  70
Figure 4.22. Systolic Blood Pressure (SBP) Responses to Two 
Exercise Bouts Following Dexamethasone 
Treatment ...................................  71
Figure 4.23. Diastolic Blood Pressure (DBP) Responses to Two 
Exercise Bouts Following Dexamethasone 
Treatment ...................................  72
Figure 4.24. Mean Arterial Blood Pressure (MABP) Response to 
Two Exercise Bouts Following Dexamethasone 
Treatment ...................................  73
Figure 4.25. Prostaglandin E2 (PGE2 ) Responses to Two 
Exercise Bouts Following Dexamethasone 
Treatment ...................................  74
ix
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ABSTRACT
This study investigated postexercise hypotension (PEH) 
in five normotensive dogs testing these hypotheses: 1) PEH is 
present in the dog model; 2) high intensity exercise of 85% 
HRmax as compared to moderate intensity exercise of 60% HRmav 
induces a greater PEH; and 3) IL-1 and its activation of PGE2 
are associated with PEH. In experiment I, it was found that 
85% HRmax exercise decreased systolic blood pressure (SBP) 
and mean arterial blood pressure (MABP) at 30 and 60 minutes 
postexercise (p<0.05). Both IL-1 and PGE2 increased 
immediately following intense exercise, although temporal 
patterns were dissimilar. During non-exercise infusion of 
ibuprofen or dexamethasone (experiment II) , blood pressure 
was not affected, but ibuprofen led to an overall inhibition 
of PGE2 . However, dexamethasone infusion led to a 
significant increase in PGE2 at 180 and 210 minutes 
postinfusion. In experiment IIIA, after intense exercise 
following ibuprofen or saline infusion, PGE2 increased at 120 
to 180 minutes postexercise. Similar results were noted 
after exercise during dexamethasone treatment (experiment 
IIIB) . In experiment IIIA & B, neither ibuprofen nor 
dexamethasone significantly affected PEH, although non­
significant reductions in PEH was observed in dexamethasone 
treated animals. However, PGE2 significantly increased after 
exercise at time points when PEH was not observed. These 
data indicate that 1) the intensity of exercise may have an 
effect on PEH, 2) there is partial support for the
x
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involvement of IL-1 and PGE2 in PEH due to their immediate 
increase after exercise although a direct relationship was 
not observed, and 3) IL-1 still remains a possible mechanism 
responsible for PEH because of trends for attenuated PEH and 
PGE2 responses following dexamethasone treatment.
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CHAPTER l: INTRODUCTION
In past years investigators have focused primarily upon 
two approaches when studying exercise in the area of 
hypertension. First, the exaggerated blood pressure response 
to acute exercise is often used as a diagnostic tool. It has 
been found that a relationship does exist between the 
exaggerated arterial blood pressure response to exercise and 
the prediction of the development of hypertension later in 
life (Schieken et al., 1981; Molineux and Steptoe, 1988;
Lauer et al., 1989; Tanji et al., 1989; and Horan and 
Lenfant, 1990) . This relationship has not always been 
upheld. One study found that the best single predictor of 
later hypertension was not handgrip or treadmill blood 
pressures but resting diastolic blood pressure (Chaney and 
Eyman, 1988). Similarly, Drory et al. (1990) studied a group 
of 262 hypertensive and normotensive females and found that 
the exercise responses of both groups were similar and 
therefore, did not appear to substantiate the predictive 
validity of exercise hypertension on future hypertension. 
Furthermore, in one of the few longitudinal studies of the 
relationship between exaggerated exercise blood pressure 
response and future hypertension, Fixler et al. (1985) found 
that exercise stress testing was not a valid method for 
predicting blood pressure elevation at two-year follow-up.
Not only is the literature on exercise hypertension as 
a predictor of future hypertension inconsistent, but there 
are also inherent problems that exist with its use as a
1
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diagnostic tool in healthy or at risk populations. Blood 
pressure values during exercise usually must be at or above 
the 85th or 90th percentile in order to have any diagnostic 
validity. Therefore, utilizing exercise hypertension as a 
diagnostic tool in at risk populations, places them at 
greater risk for abnormal cardiovascular events such as 
angina or acute ischemia. The sensitivity and specificity of 
exercise hypertension to predict future hypertension at rest 
are modest. Thirty-eight to almost 90% of those with a 
hypertensive response to exercise do not have hypertension 
upon follow-up (Benbassat and Froom, 1986). Therefore, 
widespread use of exercise testing on normal or at risk 
individuals is not recommended.
The second approach to studying the 
exercise/hypertension relationship involves chronic exercise 
as a nonpharmacologic approach for lowering arterial blood 
pressure. Over the years a number of studies (Boyer and 
Kasch, 1970; Hanson and Nedde, 1970; Choquette and Ferguson, 
1973; Ressl et al., 1977; Ernes, 1979; DePlaen and Detry, 
1980; Keleman at al., 1990; Cononie et al., 1991; Marceau et 
al., 1993; and Palatini et al., 1994) have assessed the blood 
pressure lowering effect of chronic exercise on individuals 
with essential hypertension. Based upon these and other 
studies, it has been shown that chronic exercise training 
induces an approximate 10 mmHg reduction in both resting 
systolic and diastolic blood pressures (ACSM, 1993). In 
general, the higher the stage of hypertension, the older the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
hypertensive subject, and the longer the training program, 
the more extensive are the benefits of exercise training. 
However, there are other factors that severely limit the 
study of mechanisms associated with exercise induced blood 
pressure reductions (Reaven, 1991). Exercise training not 
only lowers blood pressure in hypertensive populations but 
also promotes weight reduction (Lee et al., 1994), improves 
glucose intolerance and insulin resistance (Sinacore and 
Gulve, 1993; Depres and Lamarche, 1994; and Pratley et al., 
1995), reduces caloric intake (Stevens et al., 1993), and 
improves plasma lipoprotein-lipid profiles (Depres and 
Lamarche, 1994; and King et al., 1995) in both normotensive 
and hypertensive individuals. Because of these changes along 
with blood pressure changes, many mechanistic questions 
related to the blood pressure lowering effect of exercise 
remain difficult to explain.
Recently, however, many researchers have shifted their 
interest towards a relatively new phenomenon - the short-term 
statistically significant reduction of arterial blood 
pressure after a single bout of exercise, ie, postexercise 
hypotension (PEH). Any statistically significant reduction 
in systolic and/or diastolic arterial blood pressure below 
control levels after a single bout of exercise is considered 
PEH.
There are several advantages to studying PEH rather 
than exercise hypertension or the effects of chronic exercise 
on blood pressure. Generally, it has been found that
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
exercise as low as 40% VO2 max and as short as 3-10 minutes 
has produced the PEH response (Kenny and Seals, 1993). 
Exercising at such relatively low intensities and short 
durations does not place individuals at significant risk for 
adverse cardiovascular events. Secondly, acute changes in 
metabolic factors both during and immediately following 
exercise have been extensively studied, and therefore, are 
better understood than changes in metabolic factors 
associated with chronic exercise. Because of this, 
mechanistic questions are more easily answered with the study 
of acute exercise. Finally, the reproducible and
physiologically significant reductions of mean arterial blood 
pressure (MABP) (by 5-10 mmHg) over a 20 minute to 9 hour 
period (Kenny and Seals, 1993) makes the PEH response a 
reliable, and meaningful phenomenon to study.
Project Rationale
Hypertension (systolic blood pressure [SBP] 140 mmHg or 
greater and/or diastolic blood pressure [DBP] 90 mmHg or 
greater) afflicts as many as 50 million Americans, and it 
increases with age. The incidence of hypertension is greater 
for African-Americans than for Caucasians and in both races 
is also greater in less educated than more educated people 
(NHBPEPWG, 1993). Increases in either SBP or DBP or both 
together are associated with a higher risk of morbidity, 
disability, and mortality. Because the treatment of 
hypertension is usually expensive, particularly the expense 
of new drugs, and almost all drugs carry some risk of side
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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effects, primary prevention strategies are recommended in the 
general as well as hypertensive populations. Exercise is 
just one of the many life-style factors that has been shown 
to decrease blood pressure among hypertensives and to 
decrease the risk of future hypertension (NHBPEPWG, 1993).
A number of biologic mechanisms have been proposed as 
explanations for the blood pressure lowering effect of 
chronic exercise. However, as previously mentioned, there 
are several confounding factors that make it difficult to 
understand the mechanisms by which chronic exercise lowers 
blood pressure. Because these limitations are not as 
numerous with the phenomenon of PEH, studying PEH has several 
advantages that allow for better interpretation of the 
results.
Problem statement
The purpose of this study was to characterize the PEH 
response following two different exercise paradigms and to 
evaluate possible mechanisms associated with PEH in the dog 
model.
Hypothesis
Acute exercise has been shown to decrease blood 
pressure (PEH) in human and in animal models. Therefore, the 
following hypotheses were evaluated.
1. The PEH phenomenon is present in the dog model.
2. High intensity exercise of short duration as 
compared to low intensity exercise of longer duration induces
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
a greater blood pressure decline that lasts for a longer 
period of time.
3. Immune systems cytokines and their activation of 
prostaglandin E2 are associated with blood pressure
reductions after exercise.
Limitations
Since this study involves the dog model, the
circulatory and hemodynamic responses resulting from exercise 
or pharmacologic treatment may not apply directly to human 
populations.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 2: REVIEW OF LITERATURE
Exercise in the Dog
Humans and dogs share physiological similarities. For 
instance, the cardiovascular and respiratory systems of the 
dog are similar to those of a small man (Gay, 1984; and 
Tipton, 1986). Therefore, it is not surprising that dog and 
man respond similarly to exercise. There is a similar two- 
phase response in ventilation in both dog and man upon the 
initiation of exercise (Szlyk et al., 1981). It also has been 
shown that dogs and humans have similar biochemical responses 
to exercise (Raab et al., 1976; and Kirlin et al., 1987). The 
efficiency of running on a flat surface does not depend on 
speed in both dog and man, therefore, the approximate energy 
cost of running is about 1.0 kcal/kg/min. As with man, VO2 
(oxygen consumption) increases linearly in the dog during 
incremental increases in exercise intensity.
Small differences are noted between dog and man during 
exercise. VO2 max is greater in the dog than in man, 
averaging about a 120 ml/kg/min (Musch et al., 1985). This 
is probably a result of the dog's ability to contract its 
spleen which stores erythrocytes (Longhurst et al., 1986). 
Humans do not have this ability. Splenic contraction allows 
for an increase in the oxygen (O2 ) carrying capacity in the 
dog by releasing additional erythrocytes into the circulation 
thereby causing a greater V02 max (Longhurst et al., 1986). 
In an average man of 20-29 years of ages, V02 max is only 
about 45-51 ml/kg/min (Gettman, 1993).
7
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There are also differences with respect to heat 
dissipation even though an increase in heat production during 
exercise is positively correlated with the intensity of the 
exercise bout in both dog and man. In order to dissipate 
heat during exercise in humans, skin blood flow and sweat 
rate increases. Therefore, in humans heat dissipation occurs 
primarily through evaporation, radiation, and convection. 
Compared with humans, during exercise in dogs there is an 
increased ventilation frequency which allows air to pass in 
and out of the residual lung volume and thereby increases 
heat exchange (Goldberg et al., 1981). About 60% of heat 
dissipation is through the dog's respiratory system (Szlyk et 
al., 1981). Another mechanism unique to the dog for 
promoting heat lose is a greater perfusion of the tongue.
During exercise in the dog, the increases in cardiac 
output, stroke volume, heart rate, and blood pressure all 
increase linearly with increases in exercise workload. 
Cardiac output increases five fold (Vatner and Pagani, 1976) 
which is similar to humans. Stroke volume rises during 
exercise in the dog (Wagner et al., 1977). Ordway et al.
(1984) noted that heart rate plays a larger role in the dog 
than in man in increasing cardiac output early during the 
exercise bout. This is attributed to the greater heart rate 
reserve observed in the dog than in man. Both blood pressure 
increases and systemic vascular resistance reductions in the 
dog are similar to those of man (Fixler et al., 1976) during 
exercise. Taken together the above mentioned studies point
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
to similar physiological and cardiovascular changes in the 
dog and man both before as well as during exercise. 
Postexercise Hypotension (PEH)
Krai (1966) first found that after only 3 minutes of 
swimming blood pressure was reduced below baseline in human 
hypertensives. Similarly, Fitzgerald (1981) found that with 
25 or more minutes of sustained jogging there was a reduction 
of blood pressure below basal levels lasting from immediately 
after exercise to 24 hours after exercise. A number of 
investigators have reached the conclusion that an acute bout
of exercise (>40% of VC^max) reduces blood pressure but not 
heart rate below resting values in normotensive and 
hypertensive populations (Hagberg et al., 1987; Convertino
and Adams, 1991; Landry et al., 1992; Hara and Floras, 1992; 
and Boone et al., 1993). Acute exercise decreases systolic 
blood pressure approximately 8-12 mmHg for normotensive and 
15-30 mmHg for hypertensive persons. Although diastolic blood 
pressure does not always decrease (Hagberg et a., 1987; Boone 
et al., 1993), it has been shown to decrease by approximately 
7-9 mmHg for hypertensives and 3-5 mmHg for normotensives.
An excellent review of PEH was published by Kenny and Seals 
(1993) summarizes the above conclusions.
Pescatello et al. (1991) found significant decreases in 
blood pressure following exercise for more than 12 hours 
under free living (normal environment outside of the 
laboratory) conditions. However, under laboratory conditions 
the PEH response persists for approximately 2 to 4 hours
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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(Kenny and Seals, 1993). It may be that laboratory 
conditions mask the PEH response whereas the same subjects 
studied under free living conditions may have a prolonged PEH 
response. The duration of the PEH response continues to be 
controversial.
It is of note, however, that past studies of PEH 
utilized heterogeneous exercise intensities, and durations. 
The following list summarizes the variety of exercise 
paradigms used (Table 1).
Table 1. Exercise paradigms utilized in past studies.
Author Exercise Mode Time Intensity Decrease BP
Fitzgerald, 1981 outdoor jogging 25min 70% HR^ 10 hrs
Hannum, 1981 cycle ergometer 40min 60%VO2mat 2 hrs
Wilcox, 1982 treadmill (Rve 10min bouts) HR>120bpm 30min
Bennett, 1984 treadmill (RvelOmin bouts) HR>125bpm 60min
Paulev, 1984 cycle ergometer 20min HR>1304 hrs
Kaufman, 1987 treadmill (Rve 10min bouts) 67% HR^ 60min
Hagberg, 1987 treadmill (Three 15min bouts) 50/70%V02mat 4 hrs
Hill, 1989 weight training 60min 70%™ 2 hrs
Pescatello, 1991 cycle ergometer 30min 40/70% V02mat 12.7hrs
Floras, 1991 treadmill 45min 70%HRmat 1 hr
Boone, 1992 cycle ergometer 60min 60%VO2m£K 27min
Roras, 1992 treadmill 45min 70%HRmat 60 min
Landry, 1992 cycle ergometer 60min 55%V02mat 30min
Boone, 1993 treadmill 60min 60%VO2mat 20 min
Isea, 1994 cycle ergometer Time to exhaustion 100%V02max 2 hrs
Rueckert, 1996 treadmill 45min 70%HRmat 2 hrs
min=minutes, hr(s)=hour(s), bpm=beats per minute
Because of different exercise protocols and 
populations, proposed mechanisms associated with blood 
pressure reductions after exercise have been numerous but 
relatively unproven. Since blood pressure is the product of
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both total peripheral resistance and cardiac output, it is 
generally believed that changes in either or both contributes 
to the PEH response. It is therefore interesting that some 
investigators have found both a decreased peripheral vascular 
resistance accompanied by an increased cardiac output (Coats 
et al., 1989; Cleroux et al., 1992; and Landry et al., 1992) 
and an increased peripheral vascular resistance accompanied 
by a decreased cardiac output (Hagberg et al., 1987; Hara and 
Floras, 1992) contributing to the PEH response after 
exercise. These inconsistent results in part may be
explained by the subject populations utilized in the
different studies. Only in normotensive populations did
researchers find significant decreases in total or regional 
vascular resistance. Whereas in hypertensive populations the 
studies found a predominant decrease in cardiac output. Only 
Paulev et al. (1984) found significant reduction in blood 
pressure and total peripheral resistance after exercise in a 
group of borderline hypertensives. it may be that, 
physiologically, this subpopulation has a PEH response that 
is distinct from essential and older hypertensives.
It has been postulated that hypovolemia following an 
acute bout of exercise may contribute to PEH. However, Hara 
and Floras, (1992) reported reductions in SBP and DBP without 
significant changes in plasma volume. In fact one study 
concluded that following exercise at 70% of VC^max for 45 
minutes, plasma volume decreases by about 4% of resting 
values, and this reduction would not account for the 20%
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reduction observed in stroke volume (Hagberg et al., 1987). 
Other studies agree that it is unlikely that hypovolemia 
contributes to PEH (Kaufman et al., 1987; Floras et al., 
1991; and Cleroux et al., 1992).
In rats the decrease in stroke volume and heart rate 
following exercise, however, may be related to a fall in 
myocardial contractility (Overton et al., 1988). Kenny and 
Seals (1993) commenting on the study by Hagberg and others 
(1987) suggested that neither reductions in cardiac preload 
nor increases in cardiac afterload could account for the 
reductions seen in stroke volume, implicating alterations in 
myocardial contractility. However, this is purely
speculative and warrants further study.
The baroreceptor reflex has also been implicated in the 
PEH response. It has been theorized that a downward 
resetting of the baroreceptor reflex at the cessation of
exercise could be involved in mediating PEH. Several studies 
seem to support this contention. Bennett et al. (1984) 
illustrated a possible resetting of baroreflexes by the use 
of lower body subatmospheric or negative pressure (LBSP) 
which serves to deactivate or unload the tonic inhibitory 
influence of the baroreflex on the vasculature. In their 
study, exposure to LBSP after exercise that elicited PEH
caused a greater increase in forearm vascular resistance than 
before exercise. One limitation of this study is that 
Bennett et al. (1984) did not measure central venous pressure 
(CVP). The greater deactivation of the baroreflex observed
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after exercise might have been due to a fall in CVP. 
However, Cleroux et al. (1992) further implicated baroreflex 
control of PEH. They noted at a given level of CVP 
baroreflex unloading by LBNP a greater increase in forearm 
vascular resistance was shown after exercise that elicited 
the PEH response. These results support the possibility of 
altered baroreflex control of skeletal muscle vascular 
resistance after exercise. Although both studies examined 
hypertensives and normotensives, only hypertensive subjects 
experienced PEH. Therefore, it remains unproven that changes 
in baroreflex activity are associated with the PEH response 
in normotensive populations.
Because of the increase in body temperature during 
exercise, acute vasodilatation occurs; presumably in part 
because of the need to dissipate heat. Such thermally 
induced physiological changes may contribute to PEH. One 
strong argument against a thermoregulatory mechanism involved 
with PEH is that PEH occurs with as little as 3 minutes of 
swimming exercise (Krai et al., 1966) and therefore, should 
not have raised body temperature. Bennett et al., (1984) 
noted similar findings in which PEH was shown following an 
exercise duration of 10 minutes. Further, if
thermoregulatory induced vasodilatation contributes to PEH, 
subcutaneous or skin vascular resistance should be lower 
immediately following exercise and taper off over time when 
body temperatures return to control levels. However, to date 
no studies have addressed this issue. More direct approaches
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to studying the thermoregulatory system (subcutaneous or skin 
vascular resistance) may provide better insight into its 
relationship to PEH. Based upon this information, it remains 
unknown if vasodilatation associated with the 
thermoregulatory response during and after exercise 
contributes to PEH in humans.
Endogenous opioid pathways may play a role in PEH.
Increased plasma levels of p-endorphins have been reported
after exercise in humans (Farrell et al., 1982; and Goldfarb 
et al., 1987). In rats prolonged submaximal exercise 
increases brain (Blake et al., 1984) and cerebrospinal fluid
(Hoffmann et al., 1990) p-endorphin content, and these levels 
remain elevated 48 hours after exercise. In fact, in 
spontaneously hypertensive rats PEH was abolished after 
administration of a high dose of naloxone, a delta opioid 
receptor antagonist. Boone et al. (1993) also found that 
naloxone transiently decreased PEH in normotensive humans. 
These reports suggest opioid peptide mediation of PEH 
although not all researchers agree. Hara and Floras, (1992) 
found that naloxone administration did not prevent PEH in 
normotensive humans. Information regarding the role of 
endogenous opioid pathways in PEH are thus equivojcal, and 
further study is warranted not only in normotensive but also 
hypertensive populations.
Other circulating hormones and local metabolites may 
also mediate PEH. Plasma epinephrine concentrations have 
been shown to be either unchanged (Wilcox et al., 1987) or
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increased (Cleroux et al., 1992) after exercise. However, 
studies involving P-receptor inhibition did not show any 
attenuation of PEH in hypertensive men. Similarly, mean 
plasma vasopressin levels have been reported to be either 
unchanged (Paulev et al., 1984) or increased (Wilcox et al., 
1987) after exercise that elicited PEH. Although the 
immunoreactive atrial natriuretic factor (ANF) has been shown 
to be increased after exercise, Hara and Floras, (1992) found 
this not to be case following exercise that elicits the PEH 
response. Finally, nitric oxide is a potent vasodilator. As 
a result of shear stress and hyperemia associated with 
exercise, it is possible that nitric oxide may contribute to 
vasodilatation during and even after exercise. However, to 
date, research evaluating the role of nitric oxide in 
mediating PEH has not been completed.
Interleukin-1 (IL-1)
Interleukin-l (IL-1) is the term for two polypeptides
(IL-la and IL-iP) that possess inflammatory, metabolic,
hematopoietic, and immunologic properties. Both IL-la and P 
recognize the same cell surface receptors and share biologic 
activities (Dinarello, 1991). Additionally, IL-1 belongs to 
a group of cytokines that have overlapping biologic 
properties. These include tumor necrosis factor (TNF) and
IL-6. Interleukin-1 a and P have been cloned in the human, 
cow, pig, rabbit, rat, and mouse. Between the various animal 
species of mature IL-1, the sequence of amino acids is 60% to
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70% conserved. The gene for IL-1 is located on the human 
chromosome 2 (Webb et al., 1986). IL-1 is initially 
synthesized as a 31-kd precursor (pro-IL-1)(Hazuda et al., 
1990). Pro-IL-1 is cleaved by proteases generating a 
carboxyl terminal 17 kd peptide, called mature IL-1. The
half-life of cell associated IL-la is 15 hours whereas that
of IL-iP is 2.5 hours (Hazuda et al., 1988). Upon exposure
to endotoxin and other microbial products, IL-10 RNA 
transcription is observed within 15 minutes (Libby et al., 
1986a, 1986b), and peak accumulations of mRNA occur 3 to 4 
hours following stimulation. The most common stimulus used 
for the induction of IL-1 transcription is endotoxin. 
Naturally occurring substances such as complement components, 
thrombin, bile salts, androgen metabolites, and cytokines 
themselves can serve to initiate IL-1 transcription and 
translation (Dinarello, 1991).
The initial studies on the binding of radiolabeled IL-1 
appeared to identify a single class of intermediate affinity 
receptors. Cross-linking of radiolabeled IL-1 to its 
receptor showed that there were several proteins(30, 68, 80, 
105, and 220 kd) that specifically bind IL-1. The most 
common are the p80 IL-1R (receptor) also called the IL-1 
receptor type I (IL-lRtI) (Uhl et al., 1989), and the p68 
type II receptor (the IL-lRtll) (Matsushima et al., 1986). In 
general, IL-la binds best to the type I receptor and IL-iP to 
the type II receptor.
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The literature describing the signal transduction of
IL-1 has been unclear. However, one hypothesis has been put 
forth. IL-1 receptor complex leads to increases in cyclic 
adenosine monophosphate (cAMP) (Zhang et al., 1988; and
Shimizu et al., 1990). Mizel et al. (1990) formulated the 
following series of events:
1) IL-1/ binds to its receptor,
2) activates GTP-binding proteins,
3) activation of adenylate cyclase,
4) synthesis of cAMP,
5) protein kinase A (PKA) activation,
6) and binding of transcriptional factors to NF-kB 
which lead to increased levels of IL-1 mRNA.
However, direct evidence for activation of the GTP-binding
proteins and protein kinase A is lacking.
Hypotension. Cytokine induction during exercise may 
contribute to PEH. Acute exercise has similar
characteristics to fever, infection, and tissue trauma, all 
of which have been shown to produce increases in immune 
system cytokines. Furthermore, cytokines have been shown to 
produce large decreases in peripheral vascular resistance and 
increases in body temperature and prostaglandin production.
Exogenous administration of IL-1 (>500 ng/kg) has 
produced hypotension along with decreases in systemic 
vascular resistance in laboratory animals as well as humans 
(Dinarello, 1992). Large doses of IL-1 (>1 ng/kg) produces 
significant hypotension leading to circulatory shock (Okusawa
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
18
et al., 1988). This study also demonstrated that when IL-1 
and TNF (tumor necrosis factor), which belongs to the same 
family of cyotkines as IL-1, were co-administered in low 
doses, hypotension and a profound shock like state was 
produced in rabbits.
Furthermore, it is recognized that IL-1 induces 
increases in PGI2 (Rossi et al., 1985) and PGE2 (Warner et 
al., 1987; Libby et al., 1988; and Inoue et al., 1993) that 
could mediate the hypotensive effect. One noteworthy has 
been proposed by Dinarello (1991). The IL-1 receptor complex 
is coupled to a G-protein that activates phospholipase C 
which hydrolyzes phospholipids liberating diacylglycerol 
(DAG). DAG is further cleaved by diacyl glycerol lipase 
which gives arachidonic acid. Arachidonic acid is the major 
precursor for prostaglandin synthesis, and greater production 
of prostaglandins may cause increased temperature and 
hypotension.
Armstrong et al. (1978) found that the intravenous 
administration of PGI2 and PGE2 produced hypotension in the 
rat as well as rabbit model. Further, inappropriately low 
plasma levels of PGI2 and PGE2 have been suggested to 
contribute to the pathogenesis of hypertension (Axelrod, 
1991; Kato et al., 1992; and Arakawa, 1993). In support of 
this, Minuz et al. (1990) found a significant reduction in 
two stable breakdown products of PGI2 (6-oxo-prostaglandin FI 
alpha and 2,3-dinor-6-oxo-prostagladin FI alpha) that was 
associated with an increase in arterial pressure of about 16
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
19
mmHg (systolic) and 10 mmHg (diastolic) in patients who had 
been without antihypertensive medication for 2 weeks. Since 
prostaglandins are involved in blood pressure control, it is 
reasonable to speculate that modulation of peripheral 
prostaglandins may play a role in PEH.
Exercise. Acute exercise often initiates reactions 
very similar to the "acute phase response" to infection. This 
involves the mobilization of pro-inflammatory immune system 
cytokines. In 1973 Haight and Keatinge described changes 
similar to a fever several hours after exercise and proposed 
that the alterations may have been due to a circulating 
endogenous pyrogen, an early name for interleukin-1 (IL-1). 
Lewicki et al. (1988) noted that in humans after a single
bout of exercise endotoxin-induced secretion of IL-10 was 
augmented twofold.
The maximal activity of plasma IL-1 has been shown to 
be 3 to 9 hours after exercise in humans (Cannon et al., 
1989), a time course which does not support a significant 
role of IL-1 in PEH. The maximal PEH response occurs earlier 
than maximal plasma levels of IL-1. If IL-1 causes PEH, it 
might be expected that the nadir of PEH would coincide with 
maximal plasma levels IL-1. Unfortunately, the effects of 
acute exercise on both blood pressure and circulating IL-1 
has not been studied in the same subjects.
Most exercise studies of cytokine production involved 
in vitro stimulation of PBNC to induce detectable 
concentrations of IL-1 in blood samples taken after exercise
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and therefore, might not correlate to IL-1 production in 
vivo. One reason for using endotoxins and other microbial 
products to stimulate IL-1 production is that methods for 
measuring IL-1 are not sensitive enough to detect 
physiological concentrations in the blood. For instance, 
cytokine concentrations aren't detectable by radioimmunoassay 
usually in unstimulated samples taken after exercise (Rivier 
et al., 1994). However, earlier studies by Cannon and Kluger 
(1983) and Evans et al. (1986) utilizing bioassays found 
significant increases in plasma IL-1 activity following 
exercise. It may be that the more prudent and sensitive 
method of measuring plasma cytokine levels, both before and 
after exercise, is through the use of bioassays.
Immune system cytokines have produced significant 
biologic responses within the femtomolar range (Dinarello, 
1994) . Low concentrations of IL-1 and TNF have been shown in 
septic patients and with individuals challenged with an 
inflammatory stimulus. For example, as a result of endotoxin 
infusion, plasma levels of IL-1 increase from a normal 35 
pg/ml to a high of 69 pg/ml, and TNF levels increase from 73 
pg/ml to >500 pg/ml in humans (Cannon et al., 1990) . This 
study also showed that septic patients had plasma levels of 
TNF (119 pg/ml) and IL-1 (120 pg/ml) similar but not 
identical to healthy patients given endotoxin. Although 
hemodynamic measurements were not taken, these plasma levels 
of IL-1 and TNF indicate that they may be able to produce 
potent physiologic changes within the picomolar and possibly
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the femtomolar ranges. Because of the possibility of 
physiological effects of IL-1 at low concentrations combined 
with its short half-life (an initial fast clearance [about 3 
min] followed by slower phase [about 4 hour]) (Klapproth et 
al., 1989), earlier studies were not able to measure subtle 
but significant changes in circulating levels of IL-1, and 
it, therefore, remains possible that IL-1 might be involved 
in the PEH response.
Summary
There is no direct evidence that increased plasma 
levels of IL-1 are associated with PEH. However, the 
hypotensive effects of IL-1 are well documented as well as 
the evidence for increased concentrations of IL-1 after 
exercise. When studied in isolation, these two phenomena 
appear to be unrelated due to the lack of an appropriate 
experimental design evaluating both IL-1 and PEH. It must 
first be determined if IL-1 and PEH show a similar time 
course. If the IL-1 and PEH relationship holds true, it would 
support the hypothesis of cytokine mediated hypotension 
following an acute bout of exercise. The overall goal of the 
research described in this dissertation is twofold: first, to 
develop a dog model of PEH and second, to evaluate the role 
of cytokines in mediating the PEH observed in this model.
In experiment I of this dissertation, we first 
determined the level of exercise sufficient to produce the 
PEH response and then whether plasma levels of PGE2 and IL-1 
are increased after exercise in dogs. To further clarify the
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association between the PEH phenomenon and increased cytokine 
activity, in experiment II we characterized both the 
cardiovascular and metabolic responses to various 
concentrations of ibuprofen (an inhibitor of prostaglandin 
production) and dexamethasone (an inhibitor of cytokine and 
prostaglandin production) during nonexercised control 
studies. Not only were we interested in the cardiovascular 
responses to these substances but we were also interested in 
establishing the appropriate concentrations to be used in 
subseguent studies. To further investigate the role of 
cytokines in mediating PEH, in experiment III we investigated 
the effects of inhibiting prostaglandin through ibuprofen 
infusion (experiment Ilia) and inhibiting cytokine production 
through dexamethasone treatment (experiment Illb) on the 
blood pressure response following exercise. These series of 
studies provide sufficient data to answer some fundamental 
questions regarding the PEH phenomenon, and the role of IL-1 
and possibly other cytokines in the PEH response.
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CHAPTER 3: METHODS AMD PROCEDURES
Animal care and Preparation
With any experimental protocol designed to evaluate 
relatively new or innovative phenomena, it is prudent to use 
laboratory animal models rather than human subjects. To 
experimentally evaluate the mechanism of PEH, we used the 
normotensive dog model. Dogs were chosen because of there 
willingness to run on a motorized treadmill and because of 
their blood pressure response after exercise (based on pilot 
data). Dog exhibited a reduction of approximately 10 mmHg in 
systolic blood pressure after exercise.
Animals. Five healthy adult female dogs of mixed breed 
were acquired from a licensed dealer, authorized by the 
United States Department of Agriculture. Initially, dogs 
were quarantined for two weeks and inspected to insure that 
they were free of illness or disease. They were placed in 
stainless steel metabolic cages with epoxycoated aluminum 
mesh flooring. Dimensions of cages were 36 x 49 x 60 in., or 
12.1 square feet of floor space. All cages were located in a 
temperature controlled room (22 ± 12C). Water was provided 
ad libitum throughout the course of the individual 
experiments. Dogs were fed Purina Dog Chow (protein 21%; fat 
8%; fiber 4.5%) daily. Dogs were cared for by the Pennington 
Biomedical Research Center, Comparative Biology personnel. 
Prior to any surgical or experimental intervention, 
permission was obtained from the Louisiana State University 
Animal Care and Use Committee.
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Surgical Implantation. Prior to exercise testing of 
any kind, dogs were ovariectomized and surgically implanted 
with a venous catheter as well as with a blood pressure 
telemetry device (Model #TA11PA-D70; Data Sciences, Inc.) 
attached to a catheter inserted in the femoral or carotid 
arteries. Anesthesia was induced by thiamylal sodium given 
intravenously at a dosage of 25 mg/kg of body weight and 
maintained by 3% isoflurane/oxygen delivered through an 
endotracheal tube.
Dogs were fitted with an indwelling venous catheter 
connected to subcutaneous access ports placed on the back of 
the animal. A catheter of silicone tubing (Scientific 
Products, McGaw Park, Ill.i.d. 0.062 in., o.d. 0.125 in) was 
inserted approximately 15 cm into the jugular vein and 
secured with 2-0 silk sutures. The remaining length of the 
catheter was passed subcutaneously to an incision on the 
animal's back, and an access port was attached and inserted 
into a subcutaneous pocket. Access ports were constructed 
from a blunted 19-gauge needle connected to a leur-lock 
intravenous injection site (CharterMed, Inc., Lakewood, 
N.J.), and the needle hub and injection site were then 
covered with silastic medical adhesive (Cat #891; Dow 
Corning, Midland, Mich.). The injection port was attached to 
the catheter by silk sutures, and the assembly was then 
placed under the skin. Jugular venous catheters connected to 
subcutaneous access ports were flushed weekly (100 U of
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heparin sulfate/ml) and during the actual experiments (50 U 
of heparin sulfate/ml).
Exercise Habituation. Dogs were habituated to walking 
and running on a motorized treadmill. Initially, dogs were 
taught to run on a Quinton treadmill (Model #1849-01) at 
speeds of up to 6.4 km/h and inclines of up to 26% grade. The 
treadmill was calibrated daily to insure that accurate speeds 
and inclines were attained. After dogs had consistently (4 
or more times) displayed the ability and willingness to run 
on a treadmill at various speeds and inclines, they underwent 
a maximal exercise test to determine maximal heart rate 
response.
Maximal Exercise Testing
In past studies involving PEH, researchers have 
utilized heterogeneous exercise intensities and durations. In 
order to assess mechanisms related to PEH, we first evaluated 
the exercise bout to determine the most appropriate and 
effective protocol that elicits the PEH response. Maximal 
exercise testing was done to specifically assess the animal's 
maximal heart rate (HRmax) response in order that testing 
could be performed at specific percentages of each animal's 
maximal heart rate. Dogs were maximally exercise tested 
twice, and the average of the two tests was used to derive a 
HEmax. The two maximal exercise tests were separated by at 
least two days.
Baseline. Prior to maximal exercise testing, animals 
were fasted for 3 hours. Baseline measures of heart rate and
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blood pressure were assessed every minute for sixty minutes. 
During this time, cardiovascular assessment were done by a 
radio-telemetry system consisting of an implanted transmitter 
(Model #TA11PA-D7 0; Data Sciences, Inc., St. Paul, MN) 
attached to an arterial catheter, a cage-mounted receiver and 
a PC-based data collection system (DataQuest IV, Data 
Sciences, Inc., St. Paul, MN) while dogs were in a stainless- 
steel metabolic cage. The metabolic cage was specifically 
designed to assess heart rate and blood pressure as well as 
to infuse and sample blood with minimal stress to the dogs. 
Dogs were placed in mesh jackets to hold blood collection 
lines in place while dogs were in the metabolic cage as well 
as on the treadmill.
Exercise. The maximal exercise test consisted of two 
minute stages of incremental exercise. After an initial 
three minute warm-up (3.2 km/h, 0% grade) period, the first 
stage started at a speed of 4.8 km/h and a grade of 24% 
maintained for two minutes. Thereafter, speed or grade or 
both were manipulated at each exercise stage until there were 
no observed changes in heart rate (+2 bpm) with progressive 
increases in speed or grade or until exercise could no longer 
be maintained. During the exercise protocol, heart rate was 
assessed by radio telemetry. The protocol which we used is 
modified from the protocol of Musch et al. (1985) (Table 2).
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Table 2. Protocol for maximal exercise testing in the dog.
Stage Speed Time (min) Cumulative
km/h mph
warm-up 3.2 2 3 3
1 4.8 3 2 5
2 6.4 4 2 7
3 7.2 4.5 2 9
4 8.0 5 2 11
5 8.9 5.5 2 13
6 9.7 6.0 2 15
7 9.7 6.0 2 17
8 9.7 6.0 2 19
Postexercise. Immediately following the maximal 
exercise test, there was a recovery period of two minutes. 
Dogs were immediately placed back into the metabolic cage. 
Subsequent to the maximal exercise bout, blood pressure and 
heart rate were measured every minute by a telemetry system 
for the next 3 hours.
Submaximal Exercise Testing
Experiment I. Comparative Studies of PEH in Two 
Submaximal Exercise Paradigms in the Dog. In separate
studies, it has been shown that both increased cytokine 
activity and the PEH phenomenon occur after an acute exercise 
bout. It was critical to establish the simultaneous 
existence of both these responses and their extent of 
correlation after exercise. Therefore, during each of two 
submaximal exercise bouts both the time course of cytokine 
activity and of PEH were measured to determine their extent 
of correlation. By evaluating exercise protocols that 
differed both in intensity and duration, it was possible to 
discern at least some of the characteristics of an exercise 
bout that might be associated with changes of cytokine
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activity and PEH. The exercise paradigm which met these 
criteria would be used in follow up studies.
Five dogs participated in a continuous, acute 
submaximal exercise of either 60% HRm*v for 60 minutes or 85% 
HRmax for 30 minutes. The two submaximal exercise tests were 
separated from each other and the maximal bout of exercise by 
at least a 2-day period. Dogs served as their own controls 
where the baseline and postexercise measurements of blood 
pressure and heart rate were made while the animals were in a 
metabolic cage. During each of the submaximal exercise 
sessions, animals ran on a treadmill as speed and grade were 
progressively increased to a work load that elicited a heart 
rate of 60% or 85% of maximum heart rate response. Speed was 
not increased above 6.4 km/h (Tipton et al., 1974).
Baseline. Prior to submaximal exercise, animals were 
fasted for 3 hours. At approximately 10:00 a.m., dogs were 
taken from their home cages. Blood sampling lines were 
connected to an indwelling venous catheter. The sampling 
lines were secured under a protective vest and the dogs were 
placed into a metabolic cage where water was provided ad 
libitum. Heart rate and blood pressure were assessed for 45 
seconds every minute and averaged over a sixty minute period 
with the radio-telemetry system while dogs were in the 
stainless-steel metabolic cage. A ten milliliter blood 
sample was withdrawn at the 25th and 55th minute of the 60 
minute baseline period. Following all blood sample
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withdrawals, the blood volume removed was replaced with an 
equal amount of saline.
Exercise. At approximately 11:00, dogs were taken from 
the metabolic cage and immediately placed onto the motorized 
treadmill. Treadmill speed and incline were immediately 
manipulated to elicit an appropriate submaximal heart rate. 
Exercise intensity and duration were set at either 60% HRmay 
for 60 minutes or 85% HR^av for 30 minutes. Exercising heart 
rate was monitored by radio telemetry.
Postexercise. Immediately upon completing the
prescribed exercise bout, dogs were placed back into the 
metabolic cage where a postexercise blood sample (10 ml) was 
withdrawn. Thereafter, blood samples were withdrawn at 30 
minute intervals for the next 3 hours. A total of seven 
blood samples (70 ml) was taken during this period. 
Postexercise cardiovascular parameters were monitored every 
minute by telemetry.
Experiment II. Non-Exercise Controlled Inhibition
Studies with Ibuprofen and Dexamethasone in the Dog. To
further clarify the association between PEH and increased 
cytokine activity, it was important to characterize both the 
cardiovascular and metabolic responses to the infusion of 
ibuprofen and dexamethasone during nonexercise control 
studies. These nonexercise studies were performed to 
characterize and evaluate some of the possible confounding 
effects of a given dose of ibuprofen or dexamethasone.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Baseline. Prior to controlled inhibition studies, five 
dogs were fasted for 3 hours (from 07:00 hrs to 10:00 hrs). 
At approximately 09:00 hrs dogs were taken from their home 
cages and placed in a metabolic cage where baseline data was 
collected for sixty minutes. At the end of the sixty minute 
period (approximately 10:00 hrs), dogs were infused with 
either ibuprofen or dexamethasone. All baseline
cardiovascular assessments were made with a radio-telemetry 
system while dogs were in a stainless-steel metabolic cage. 
Fifteen milliliters of whole blood were withdrawn (a total of 
30 ml) at the 25th and 55th minute of the baseline period and 
aliquoted (5 ml/per tube) into vacutainer plain, lithium 
heparin, and EDTA tubes which were centrifuged and analyzed 
at a later time. An amount of saline (USP 0.9%) equal to the 
amount of blood withdrawn was injected intravenously after 
each blood withdrawal to insure adequate blood volume.
Ibuprofen Infusion. Each dose of ibuprofen (a-methyl- 
4-[2-methlpropyl]-benzeneacetic acid, Sigma Chemical Co., St. 
Louis, MO) was dissolved in 5 mis of water with 500 ul of 1 N 
NaOH. The pH was then adjusted to 7.4 with 2-3 drops of 1 N 
HC1 (Scherkl and Frey, 1987). After pH adjustments were 
made, the ibuprofen solution was filtered through a 0.2 um 
sterile non-pyrogenic filter (Gelman Sciences, Acrodisc, 
Product #4192) . Immediately after the one-hour baseline 
period, 5 mg/kg of ibuprofen was administered intravenously 
(Byrick et al., 1992). After ibuprofen infusion, the 
catheter was flushed with approximately 20 mis of saline.
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Dexamethasone Infusion. Dexamethasone (Azium, 2mg/ml 
solution [0.5 mg/kg]) was given immediately following the 
one-hour baseline period (Nakamoto et al., 1992). Again, 
after each drug infusion, the indwelling catheter was flushed 
with approximately 20 ml of saline.
Since the plasma half-life of ibuprofen (3.7 to 5.8 
hrs) (Scherkl and Frey, 1987) and dexamethasone (3 to 3.5 
hrs) (Greco et al., 1993) is longer than 3 hours and the 
postexercise hypotensive phenomenon (60 min based upon our 
pilot data), a second dose of either substance was not 
required.
Postinfusion. Beginning 1 hour after drug infusion, 
blood samples (15 ml) were withdrawn at 30 minutes intervals 
for the next 3 hours. The animals were not exercised for 
this protocol. A total of seven blood samples (105 ml) was 
taken during this period. Postinfusion cardiovascular 
parameters were monitored every minute by radio-telemetry.
Experiment III. Inhibition Studies with Ibuprofen and 
Dexamethasone: Exercise Studies (85% HRmax for 30 minutes)
in the Dog. IL-1 induces production of PGE2 (Warner et
al., 1987), and exogenous PGE2 has been shown to produce 
hypotension (Armstrong et al., 1978). Currently, the 
relative contribution of IL-1 stimulated production of 
prostaglandins to PEH currently is unknown. Therefore, we 
investigated the effects on PEH of inhibiting PGE2 production 
with ibuprofen compared to saline control.
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Experiment A. Prior to exercise (85% HRmax for 30 
minutes), dogs were fasted for three hours (from 07:00 hrs to 
10:00 hrs). At approximately 09:00 hrs, dogs were taken from 
their home cages and placed in a metabolic cage where 
baseline blood pressure and heart rate data were collected. 
Once the animal was placed into the metabolic cage, an 
observation period of at least thirty minutes allowed enough 
time for systolic blood pressure to stabilize. The criteria 
for adequate baseline measures of systolic blood pressure 
were established for each dog independently and based upon 
previous average baseline data collected from each dog. 
During two consecutive two minute intervals, SBP was not to 
have decreased more than 5 mmHg. After blood pressure 
stabilized, there was a sixty minute baseline period where 
heart rate and blood pressure were assessed every minute.
Ten milliliters of whole blood were withdrawn (a total 
of 20 ml) at the 25th and 55th minute of the baseline period 
and placed in vacutainers of plain (4 ml) , lithium heparin (3 
ml), and EDTA (3 ml) tubes kept on ice until centrifuged and 
plasma or serum samples were permanently stored at a 
prescribed temperature for analysis at a later date. An 
amount of saline (USP 0.9%) equal to the amount of blood 
withdrawn (10 ml) was injected intravenously after each blood 
withdrawal to insure adequate blood volume.
Each dose of ibuprofen was dissolved in 5 mis of water 
with 500 ul of 1 N NaOH. The pH value was then adjusted to 
7.4 with 2-3 drops of 1 N HCl (Scherkl and Frey, 1987).
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After pH adjustments were made, the ibuprofen solution was 
filtered through a 0.2 um sterile non-pyrogenic filter 
(Gelman Sciences, Acrodisc, Product #4192).
At the end of the baseline period (approximately 10:30 
hrs) , dogs were either infused with a bolus dose of 5 mg/kg 
of ibuprofen (Byrick et al., 1992) or an equivalent amount of 
0.9% USP saline (5 mis). After drug or saline infusion, the 
catheter was flushed with approximately 20 mis of 0.9% USP 
saline to insure that all of the dose entered the systemic 
circulation.
Following the infusion of ibuprofen or saline, dogs 
were monitored for an additional thirty minute period. At 
minute 25 of this period another blood sample (approximately 
10 ml) was taken prior to the start of exercise (85% HRmax 
for 30 min).
Upon the completion of the exercise bout, blood samples 
(10 ml) were withdrawn immediately after exercise (within a 
five minute period) and at 30 minutes intervals for the next 
3 hours. A total of seven blood samples (70 ml) were taken 
during this period. A total of 100 ml of blood was sampled 
during this ibuprofen protocol. All cardiovascular parameters 
were monitored every minute for 3 hours following exercise by 
radio-telemetry.
Experiment B. It has been shown that dexamethasone is 
not only a suppressor of cyclooxygenase-2 (COX-2) (Masferrer 
et al., 1990) but also causes partial inhibition of cytokine 
mRNA accumulation and markedly depresses the translation of
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the mRNA that is produced (Han et al., 1990). This study by 
Masferrer et al. (1990) also showed that dexamethasone given 
in vivo resulted in a 40% reduction in the radioactivity 
associated with radiolabeled COX-2, and its major effect was 
the 80% inhibition of LPS (lipopolysaccaride) stimulated COX- 
2. Since dexamethasone inhibits the induction of the 
inflammatory response related COX-2, and this mechanism may 
be involved in the PEH phenomenon, we examined 
dexamethasone1s effect on PEH in five dogs.
All dexamethasone data were compared to those of a 
saline infusion period performed immediately prior to 
exercise testing on a separate occassion. Due to both the 
length of time of the dexamethasone pre-treatment period and 
the physiological effects of dexamethasone that have been 
shown to persist for weeks following the discontinuation of 
treatment, all saline control protocols were conducted before 
the dexamethasone treatment period. All baseline, exercise, 
and postexercise methods and procedures were similar to those 
of experiment IIIA.
Baseline 12 hour blood pressure and heart rate data 
were acquired for at least five days prior to exercise and 
analyzed every hour during the period between 18:30 hours and 
06:30 hours. These five days served as the baseline periods 
for a six to eleven day dexamethasone treatment period (0.5 
mg/kg/day).
Dexamethasone (Decadron, 9-fluoro-liP, 17, 21-
trihydroxy- 16a-methylpergna-l, 4 diene-3,20-dione, Merck &
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Co., Inc.) was given orally in tablet form for a period of 
six to eleven days. Depending upon an individual dog's blood 
pressure response, the animal remained on dexamethasone at 
least 4 days or until a reasonable increase in blood pressure 
was observed. Systolic blood pressure was to have increased 
by about 5 mmHg prior to submaximal exercise testing. Recent 
research in dogs utilizing dexamethasone found that in order 
for dexamethasone to decrease prostaglandin concentrations 
there should also be a concomitant increase in blood pressure 
(Nakamota et al., 1991, 1992). Without an increase in blood 
pressure these investigators found no inhibition of 
prostaglandins; in fact, to the contrary, there was an 
increase in prostaglandins. Dexamethasone was given at 
approximately the same time each morning throughout the six 
to eleven day treatment period.
Between six and eleven days after the start of 
dexamethasone and immediately prior to exercise (85% HRmax 
for 30 minutes), dogs were fasted for three hours 
(approximately 07:00 hrs to 10:00 hrs). On the day of 
exercise testing at approximately 09:00 hrs, dogs were taken 
from their home cages and placed in a metabolic cage where 
baseline blood pressure and heart rate data were collected. 
Once the animal was placed into the metabolic cage, an 
observation period of at least thirty minutes allowed enough 
time for systolic blood pressure to stabilize and baseline 
data was collected for one hour.
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While on dexamethasone, dogs were exercised twice on 
separate days starting from 4 to 9 days following the 
initiation of dexamethasone treatment to determine the 
consistency of the response to exercise at different time 
points. Exercise 1 was performed after dogs were on 
dexamethasone for at least four days and/or, SBP became 
elevated by at least 5 mmHg. Exercise 2 was separated from 
exercise 1 by at least a two-day period. Baseline and 
postexercise blood pressure and heart rate responses to 
dexamethasone treatment during exercise 1 were compared with 
those of a saline control period as well as with those of 
exercise 2.
Upon the completion of the exercise bout, postexercise 
blood samples (10 ml) were withdrawn immediately after 
exercise (within a five minute period) and at 30 minutes 
intervals for the next 3 hours. A total of seven blood 
samples (70 ml) were taken during this period. A total of 90 
ml of blood was sampled during this dexamethasone protocol. 
All cardiovascular parameters were monitored every minute for 
3 hours by radio-telemetry.
Analysis of Data
Blood Pressure and Heart Rate. All resting and
exercise blood pressure and heart rate measures were assessed 
by a radio-telemetry system consisting of an implanted 
transmitter (Model #TA11PA-D70; Data Sciences, Inc., St. 
Paul, MN) attached to an arterial catheter, a cage-mounted 
receiver and a PC-based data collection system (DataQuest IV,
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Data Sciences, Inc., St. Paul, MN) while dogs were on the 
treadmill as well as in the stainless-steel metabolic cage. 
Blood pressure and heart rate means were an average of a 45 
second sampling period taken every minute. All 30 and 60 
minute intervals of time were an average of the 30 or 60 
preceding minutes.
Posture Effects. Since some of the dogs' telemetry 
device was attached to a catheter inserted in the femoral 
artery, changes of posture may have had an impact on the 
blood pressures recorded while the dogs were in the metabolic 
cage. Therefore, to avoid acquiring false positive data as a 
results of the effects of posture on blood pressure, dogs 
were observed and postural data was recorded every minute 
during all laboratory protocols. Dogs were observed to be 
either sitting (Si), standing (St), or lying (L) for most of 
a one minute period and this was recorded. The data were 
scored by the frequency with which postures occurred. The 
number of occurrences was analyzed in blocks of 30 minute 
periods for differences between time intervals.
Plasma and Serum. In all dogs, whole blood was
collected and centrifuged at HOOg for 5 minutes at 4°C for
plasma samples, or HOOg for 10 minutes at 4 2 c for serum 
samples. Plasma samples were stored at -202C while serum
samples were stored at -80°C until analyzed.
Prostaglandin E2 . Concentrations of PGE2 were 
measured using a specific radioimmunoassay (RIA) (Boudreau et 
al., 1992). Phosphate buffered saline PBS,(pH 7.0) gelatin
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(0.1%) was used as an incubation buffer. The total volume of 
PBS-gelatin plus the sample was 500 ul. The standard 
solution (20-100 ng/ml PBS-gel) was prepared by diluting 10- 
50 ul of the stock solution (5 ug/ml ethanol or acetonitrile) 
in 2.5 ml of PBS-gelatin. The standard solution was prepared
just before the assay was run. Approximately 10,000 dpm of
• • » 1radioactive eicosanoid ( I-PGE2 and New England Nuclear,
and Amersham) in 100 ul PBS-gel was added to each tube. RIA 
specific activity was in the range of 20 to 200 ci/mmol. Two 
hundred microliters of plasma with appropriate titer (NRS 
1:400) in PBS-EDTA (0.05 M) was then added to each tube. 
Preparations were incubated for 12 hours. The PGE2 
separation was done by the double antibody technique (anti­
rabbit gammaglobulin [ARGG] 200 ul). Preparation was then 
incubated another 48 hours. The incubation mixture was 
diluted with 2.0 ml of PBS before the centrifugation 
(l,500g) in order to minimize the amount of residual unbound- 
antigen left over in the final precipitate. Separation of the 
immunocomplex (the first antibody to the second antibody) was 
achieved by centrifugation, and decanting the supernatant 
containing tbo unbound antigen. The final immunoprecipitate 
(300 ul) was solubilized in 0.05 normal NaOH before the 
addition of scintillation cocktail (3.5 ml). Samples were 
counted within 1% of counting error.
The minimum amount of PGE2 detectable by this assay is 
41 pg/ml, and the percent binding was 32.5. The RIA data 
were analyzed by a computer program (Duddleson et al., 1972)
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based on the linearity of the logit transformation of the 
dose response curve. The least square regression analysis 
with weighing procedure was a part of the program. The logit 
(Y) parameters were weighed according to the reciprocal of 
their variances. The program performed a logit
transformation on the data obtained form the standard curve 
and computed the mean level of antigen with a 95% confidence 
limit for each sample.
Bioassay of IL-1. IL-l-like activity in plasma
samples was assessed by cytolytic assay using human melanoma 
subclone A375S2 (Nakai et al., 1988; and Yamashita et al., 
1994) provided by LSU School of Veterinary Medicine's Cell 
Culture Faciltiy. The cells (2 x io3) were cultured together 
with recombinant human (rh) IL-10 (R&D Systems Inc., 
Minneapolis, MN), (final concentration 0.01-10 U/ml,) diluted 
serially for a standard curve or 0.01 ml of samples in a 
final volume of 0.2 ml/well in Eagle's Minimal Essential 
Medium supplemented with 10% fetal bovin serum in a 96 well 
flat-bottom tissue culture plate. After a 96 hour incubation 
at 37°C in 5% CO2 , 0.05 ml of 0.05%, neutral-red dye was 
added to each well, and the plate was incubated for 2 hours 
at 37°C. After washing the plate twice with 100 ul of 
phosphate buffered saline (PBS), 0.1 ml of 50% ethanol in PBS 
was added to each well for extraction of dye incorporated 
into viable cells. The optical density (O.D.) was read at
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540 nm on an ELISA palte reader. All determinations were 
performed in triplicate.
Statistics. Samples for a power analysis were 
computed using multiple ranges for SBP, DBP, MABP, and HR. 
Since two levels of power were of interest (a minimum range 
of 80% and 90%), two different sets of sample sizes were 
approximated. Thus, for each variable an ideal sample size 
was found using a function of power and the minimum range. 
The variance was also needed to compute the sample size. 
Since the true variance was not known, the variance was 
approximated using data from pilot studies of PEH in the dog.
Power analysis revealed that five dogs were needed to obtain 
blood pressure differences between baseline and post exercise 
measures (80% power, p<0.05).
During all experiments, differences between resting and 
recovery blood pressures were analyzed by a within subjects 
analysis of variance with repeated measures (Barcikowski and 
Robey, 1984). For correlations and effects of different 
treatments, the differences between baseline and post­
exercise were used for analysis.
When a statistically significant (p< 0.05) difference 
occurred, a post-hoc analysis (protected LSD) was performed 
to determine when those differences were statistically 
reliable.
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CHAPTER 4: RESULTS
The PEH response was studied in five normotensive mixed 
breed female dogs. Three experimental protocols were 
performed to characterize PEH and the hemodynamic response to 
pharmacologic treatment with ibuprofen and dexamethasone, in 
both non-exercise and exercise paradigms. Dependent measures 
included SBP, DBP, MABP, HR, and plasma concentrations of IL- 
1 and PGE2 . Baseline and postexercise measures of these 
dependent variables were taken, and dogs served as their own 
controls within each exercise paradigm. Differences between 
resting and postexercise variables were analyzed by a 
repeated measures analysis of variance.
Experiment I
One of the goals of this dissertation was to 
characterize the PEH phenomenon in the dog. Therefore, in 
experiment I, the primary objective was to examine PEH 
following two different exercise paradigms - an exercise bout 
of 85% HRmax for 30 minutes and an exercise bout of 60% HRma* 
for 60 minutes. The actual intensity of each exercise
paradigm was 85.2% HRn^ (187±1.6 bpm) and 62.0% HRmax (136±8 
bpm) . Exercise blood pressures as well as heart rates were 
greater in the former compared to the later exercise paradigm 
(p<0.05). When individual time points were compared, no 
significant differences were found between the 85% HRmav 
exercise and the 60% HRma* exercise for all dependent 
measures of HR and blood pressure. Therefore, only within 
exercise differences will be reported. With the 60% HR^ax
41
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exercise, HR was significantly decreased at 30, 60, 90, 150, 
and 180 minutes postexercise (Figure 4.1); whereas, with the 
85% HRmay exercise, HR was unchanged from baseline levels for 
the first 30 minutes of the postexercise period but decreased 
significantly thereafter. All blood pressures were
significantly increased from baseline during exercise. 
Exercising SBP, MABP, and DBP were all greater with exercise 
of 85% HRmav for 30 minutes than with exercise of 60% HRn,av 
for 60 minutes (p<0.05) . With the 85% HRnav exercise, but 
not the 60% HRmav exercise, both SBP and MABP were reduced at 
30 minutes postexercise (-11±3.4 and -5±2.5 mmHg for the SBP
and MABP respectively) and 60 minutes postexercise (-12±3.4
and -7±2.5) (Figure 4.2 and 4.3). No significant differences 
from baseline were found in DBP.
In the analysis of PGE2 there were significant 
differences (Figure 4.4) between two exercise paradigms. 
However, within the 85% HRmax exercise, there was an overall 
increase from baseline in plasma levels of PGE2 (p<0.05); 
plasma levels of PGE2 became significantly increased from 
baseline at 5 and 90 minutes postexercise. An overall 
increase in plasma levels of PGE2 was not found with the 
exercise bout of 60% HRmay although immediately following 
exercise (5 minutes after) PGE2 levels were significantly 
increased from baseline levels.
There was no overall significant effect of exercise on 
plasma levels of IL-1 and no significant differences were
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observed between the two exercise bouts (Figure 4.5).
However, the 60% HRnav exercise produced a significant
increase from baseline in plasma levels of IL-1 at 180
minutes postexercise, whereas the 85% HR^ y  exercise caused a 
significant rise from baseline in IL-1 at 5 minutes
postexercise.
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Figure 4.1. Baseline (BL) and postexercise heart rate (HR) 
response to 85% KRmav exercise for 30 minutes and 60% HRmax 
exercise for 60 minutes. ** denotes significant group 
differences (p< 0.05). * and # denote significant differences 
from baseline for exercise of 60% HRmay for 60 minutes and 
85% HRmax for 30 minutes, respectively. EX=Exercise
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Figure 4.2. Baseline (BL) and postexercise systolic blood 
pressure (SBP) response to 85% HRm**- exercise for 30 minutes 
and 60% HRmax exercise for 60 minutes. ** denotes 
significant group differences (p< 0.05). * and # denote 
significant differences from baseline for exercise of 60% 
HRmax f°r 60 minutes and 85% HRmav for 30 minutes, 
respectively. EX=Exercise
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Figure 4.3. Baseline (BL) and postexercise mean arterial 
blood pressure (MABP) response to 85% HRmax exercise for 30 
minutes and 60% HRmax exercise for 60 minutes. ** denotes 
significant group differences (p< 0.05). * and # denote
significant differences from baseline for exercise of 60% 
HRmax f°r 60 minutes and 85% HRmax for 30 minutes, 
respectively. EX=Exercise

























BL 5 30 60 90 120 150 180
Time (min)
Figure 4.4. Analysis of prostaglandin E2 (PGE2 ). Baseline 
(BL) and postexercise plasma PGE2 response to 85% HRn,ay 
exercise for 30 minutes and 60% HRmay for 60 minutes. * and 
# denote significant differences from baseline for exercise 
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Figure 4.5. Analysis of interleukin-1 (IL-1). Baseline (BL) 
and postexercise plasma IL-1 response to 85% HRmay exercise 
for 30 minutes and 60% HRmav exercise for 60 minutes. * and 
# denote significant differences from baseline for exercise 
of 60% HRmax f°r 60 minutes and 85% HR^av for 30 minutes, 
respectively.
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Experiment II
Experiment II was designed to evaluate the hemodynamic 
and PGE2 responses to pharmacologic treatment with ibuprofen 
(5 mg/kg) or dexamethasone (0.5 mg/kg) under nonexercise 
conditions. Although slightly decreased below baseline 
levels, there were no significant HR changes at 30 minute 
post inf us ion as a result of ibuprofen or dexamethasone 
administration (Figure 4.7). However, both ibuprofen and 
dexamethasone decreased HR at 60, 90, 120, 150, 180, and 210 
minutes postinfusion (p< 0.05). At minute 240 following 
ibuprofen infusion, HR was not significantly different from 
baseline values. However, following dexamethasone infusion, 
HR were still significantly decreased from baseline values at 
240 minutes postinfusion. Postinfusion blood pressure during 
the two pharmacologic treatments were not significantly 
different from baseline blood pressure. Changes were observed 
with respect to plasma concentrations of PGE2 (Figure 4.7).
Following infusion of ibuprofen, plasma concentrations 
of PGE2 were lower at 60 minutes compared to baseline (p< 
0.05). However, dexamethasone caused significant increases 
in PGE2 from baseline at minute 180 and 210 postinfusion. 
There were no differences from baseline observed for plasma 
PGE2 concentrations at all other postinfusion times during 
both treatments.
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Figure 4.6. Baseline (BL) and postinfusion heart rate (HR) 
response for nonexercised controlled infusions of ibuprofen 
or dexamethasone. * and # denote significant differences 
from baseline for the ibuprofen and dexamethasone treatments, 
respectively (p< 0.05).
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Figure 4.7. Baseline (BL) and postinfusion prostaglandin E2 
(PGE2) response for nonexercised controlled infusions of 
ibuprofen or dexamethasone. * and # denote significant 
differences from baseline for ibuprofen and dexamethasone 
treatments, respectively (p< 0.05).
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Experiment IIIA
Further exploring the potential role of cytokines in 
mediating PEH, this experiment was designed to compare the 
effects of ibuprofen or saline infusion on blood pressure, 
HR, and plasma levels of PGE2 following an 85% HRmav exercise 
bout for 30 minutes. Similar to the first experiment, when 
individual time points were compared, no significant 
differences were found between ibuprofen and saline treatment 
periods for all dependent measures. Hence, there was no 
effect of ibuprofen on PEH. Therefore, each dependent 
measure of HR, SBP, MABP, and DBP for the ibuprofen treatment 
period was statistically combined with those of the saline 
treatment period. The exercising HR for experiment IIIA was 
significantly increased from baseline (Figure 4.8). HR was 
increased at 30 minutes postexercise (p< 0.05), leveled off 
slightly below baseline at 60 minutes postexercise, and 
decreased significantly below baseline during the subsequent 
postexercise time points (p< 0.05). All blood pressures were 
significantly increased during exercise. SBP was
significantly lower than baseline for both the 30 and 60 
minute of the postexercise period (Figure 4.9). For both 
MABP and DBP, only at 60 minutes postexercise were values 
lower than baseline (p< 0.05) (Figure 4.10 and 4.11). These 
differences diminished during the subsequent postexercise 
time points.
No difference were observed in plasma concentrations of 
PGE2 between saline and ibuprofen treatment periods.
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Therefore, as with blood pressure and heart rate variables, 
all PGE2 measurements were combined for the statistical 
analysis. Initial plasma concentrations of PGE2 were 
unaffected by exercise, however, at 120, 150, and 180 minutes 
of postexercise, PGE2 concentrations increased significantly 
(Figure 4.12).
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Figure 4.8. Ibuprofen (IB) vs. Saline (NaCl) Control Heart 
Rate (HR) Responses. Baseline (BL), exercise (EX), and 
postexercise HR response to 85% HfUav exercise for 30 
minutes. Since no group differences where observed, * denote 
significant differences from baseline for both IB and NaCl 
treatment groups (p< 0.05).
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Figure 4.9. Ibuprofen (IB) vs. Saline (NaCl) Control
Systolic Blood Pressure (SBP) Responses. Baseline (BL),
exercise (EX), and postexercise SBP response to 85% HRmax
exercise for 30 minutes. Since no group differences where
observed, * denote significant differences from baseline for 
both IB and NaCl treatment groups (p< 0.05).
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Figure 4.10. Ibuprofen (IB) vs. Saline (NaCl) Control Mean 
Arterial Blood Pressure (MABP) Responses. Baseline (BL) , 
exercise (EX), and postexercise MABP response to 85% HRmax 
exercise for 30 minutes. Since no group differences where 
observed, * denote significant differences from baseline for 
both IB and NaCl treatment groups (p< 0.05).
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Figure 4.11. Ibuprofen (IB) vs. Saline (NaCl) Control
Diastolic Blood Pressure Responses (DBP). Baseline (BL),
exercise (EX) , and postexercise DBP response to 85% HRn,^
exercise for 30 minutes. Since no group differences where
observed, * denote significant differences from baseline for 
both IB and NaCl treatment groups (p< 0.05).
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Figure 4.12. Ibuprofen (IB) vs. Saline (NaCl) Control Plasma 
Prostaglandin E2 (PGE2) Responses. Baseline (BL), exercise 
(EX), and postexercise PGE2 response to 85% HRmax exercise 
for 30 minutes. Since no group differences where observed, * 
denote significant differences from baseline for both IB and 
NaCl treatment groups (p< 0.05).
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Experiment IIIB
The objective of experiment IIIB was to evaluate the 
effect of pre-treatment with dexamethasone on the PEH 
response. As stated previously, dexamethasone has been shown 
to block mRNA synthesis and accumulation of immune system 
cytokines. It has also been shown to preferentially block 
those inflammatory pathways leading to the production of 
PGE2 . Within this inflammatory pathway, dexamethasone blocks 
cyclooxygenase-2 (COX-2). Therefore, it was hypothesized 
that if IL-1 mediates PEH, dexamethasone treatment would lead 
to an attenuation of the PEH response.
Following a 5-day baseline period, dogs were treated 
with dexamethasone for a total period ranging from 6 to 11 
days that depended upon an individual dogs1 blood pressure 
response to dexamethasone. All dogs remained on
dexamethasone for at least 4 days or until the dogs' systolic 
blood pressure was elevated by at least 5 mmHg before the 
initiation of an exercise protocol. While on dexamethasone, 
dogs were exercised twice. Exercise 1 was performed after 
dogs were on dexamethasone for at least four days and/or, SBP 
became elevated by at least 5 mmHg. Exercise 2 was separated 
from exercise 1 by at least a two-day period. Baseline and 
postexercise blood pressure, heart rate, and prostaglandin 
responses to dexamethasone treatment during exercise 1 were 
compared with those of a saline control period as well as 
with those of exercise 2.
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Dexamethasone Treatment Across Days. Because of the a 
priori criteria of a 5 mmHg increase in SBP before the 
initiation of any submaximal exercise testing, some dogs were 
exercised sooner after the initiation of dexamethasone 
treatment than others. Since all dogs were treated with 
dexamethasone for at least a 4-day period prior to exercise, 
differences from baseline were reported only for these four 
days and the days on which the dogs were exercised. Although 
HR was decreased on day 1 following dexamethasone treatment, 
decreases were not significant until day 2, and remained 
decreased through day 4 as well as on those days when 
exercise was performed (Figure 4.13). By the third day after 
dexamethasone treatment was discontinued, HR was no longer 
significantly different from baseline. SBP, DBP, and MABP 
were all decreased on day 1 following dexamethasone treatment 
(p <0.05) (Figure 4.14). SBP became significantly elevated 
from baseline on days 3 and 4 as well as on both exercise 
days following dexamethasone treatment, whereas DBP and MABP 
were never elevated. Plasma levels of PGE2 increased 
significantly from baseline on day 2, and day 3 following 
dexamethasone treatment (Figure 4.15). Although plasma 
levels of PGE2 remained elevated, levels were not 
statistically significant on day 4 following dexamethasone 
treatment. In contrast, the days on which exercise (both 
exercise 1 and 2) was performed plasma levels of PGE2 were 
back to baseline levels.
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Exercise 1 Following Dexamethasone Treatment vs. Saline 
Control. Exercise significantly increased all HR and blood 
pressures both following dexamethasone treatment and 
following saline infusion (Figures 4.16, 4.17, 4.18, and
4.19). When individual time points were compared, no 
significant differences were found between exercise 1 of 
dexamethasone treatment and saline treatment periods for all 
dependent measures of HR and blood pressure. Hence, compared 
to saline treatment, dexamethasone had no significant effect 
on blood pressure or HR both during and following exercise. 
Therefore, only within exercise differences are reported.
At 30 minutes of postexercise HR was significantly 
increased from baseline for both exercise bouts. However, 
between the 60-180 minutes postexercise for the exercise bout 
performed under saline treatment, HR was significantly lower 
than baseline. This was not the case with postexercise time 
points of HR following treatment with dexamethasone, which 
were not significantly different from baseline at any time 
point after the first 30 minutes postexercise. Further, at 
no point following exercise were SBP, DBP, and MABP 
significantly different from baseline levels for exercise 
following dexamethasone treatment. However, for exercise 
following saline infusion, SBP was significantly decreased at 
both 30 and 60 minutes of postexercise whereas both DBP and 
MABP were only significantly decreased below baseline at 60 
minutes postexercise.
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No difference were observed in plasma concentrations of 
PGE2 between saline and dexamethasone treatment periods. 
Initial plasma concentrations of PGE2 were unaffected by 
exercise following saline administration, however, at 120, 
150, and 180 minutes of postexercise, PGE2 concentrations 
increased significantly (Figure 4.20). The same held true 
for PGE2 response following exercise during dexamethasone 
treatment except PGE2 values became significant at 150 
minutes and lasted only until 180 minutes postexercise.
Exercise 1 vs. Exercise 2. Exercise significantly 
increased HR, SBP, and MABP during exercise 1 and 2 (Figures 
4.21, 4.22, 4.23, and 4.24). However, although exercise
significantly increase DBP during exercise 1, DBP was 
unchanged during exercise 2. When individual time points 
were compared, no significant differences were found between 
exercise 1 and exercise 2 for all dependent measures of HR 
and blood pressure. Therefore, only within exercise 
differences are reported. At 30 minutes of postexercise 
compared to baseline values, HR was increased (p< 0.05) in 
exercise 1. However, HR approached baseline levels at minute 
60 postexercise and remained at baseline levels during the 
subsequent postexercise time points. Although in exercise 1 
SBP, MABP, and DBP were lower than baseline values, at no 
point during postexercise measurement were these blood 
pressures significant.
In exercise 2 HR was significantly increased at 30 
minutes postexercise, but decreased at 120 and 180 minutes of
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postexercise (p< 0.05). At minute 60, 90, and 120 minutes 
of postexercise all blood pressures were significantly lower 
than baseline within this exercise paradigm. There were no 
differences between baseline and other postexercise time 
points.
Following both exercise 1 and 2, plasma concentrations 
of PGE2 increased significantly from baseline at 90 to 180 
minutes postexercise (Figure 4.25).
Posture Effects of All Experiments
Because the telemetry device in some dogs was placed on 
the lower left flank below heart level, when dogs sat 
hydrostatic pressure may have affected blood pressure 
measurement. A false positive PEH response may have resulted 
from this effect of posture in dogs that sat more during 
baseline period than postexercise (or postinfusion) periods 
or if dogs sat less during the 30 to 60 minute postexercise 
(or postinfusion) time points than during later time points. 
Therefore, dogs were observed, and postural data was recorded 
every minute throughout the course of all experiments.
As expected, there were no significant changes in the 
frequency of postexercise (or postinfusion) sitting postures 
from those of baseline within experiments I, II, IIIA, and 
IIIB. Further, within experiment I there was no significant 
difference in sitting postures between the exercise bouts of 
85% HRjnax and 60% HRn^. Similarly, no significant 
differences were found between the non-exercise ibuprofen and 
dexamethasone infusions of experiment II. There was also no
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significant difference found in sitting postures between 
exercise 1 and exercise 2 following the dexamethasone 
treatment, or between exercise 1 of the dexamethasone 

















BLx5 Dex1Dex2Dex3 Dex4Ex1 Ex2 Rec1Rec2 Rec3 Rec4 Rec5
Time (days)
Figure 4.13. 24-hour Heart Rate. A 5-day average baseline
(BLx5) heart rate, its response to dexamethasone (Dex) 
treatment across 4-days and on two separate day on which dogs 
were exercised (Ex) as well as recovery (Rec) heart rate 
across a 5-day post-treatment period. * denotes significant 
differences from a 5-day average baseline (p< 0.05).
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Figure 4.14. 24-hour Systolic (SBP), Diastolic (DBP), and
Mean Arterial Blood Pressures (MABP). A 5-day average 
baseline (BLx5) blood pressures, their response to 
dexamethasone (Dex) treatment across 4-days and on two 
separate day on which dogs were exercised (Ex) as well as 
recovery (Rec) blood pressures across a 5-day post-treatment 
period. * denotes significant differences from a 5-day 
average baseline (p< 0.05).
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Figure 4.15. Baseline (BL) Prostaglandin E2 (PGE2 ), 
Dexamethasone (Dex) Treatment across a 4-day period, and on 
Days of Exercise (Ex). * denotes significant differences
from baseline (p< 0.05).
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Figure 4.16. Heart Rate (HR) Responses to Exercise Following 
Dexamethasone (Dex) and Saline (NaCl) Treatment. Baseline 
(BL), exercise (EX), and postexercise HR response to two 
exercise bouts at 85% HRma* for 30 minutes. # and * denote 
significant differences from baseline following Dex and NaCl 
treatment, respectively (p< 0.05).
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Figure 4.17. Systolic Blood Pressure (SBP) Responses to 
Exercise Following Dexamethasone (Dex) and Saline (NaCl) 
Treatment. Baseline (BL), exercise (EX), and postexercise 
SBP response to two exercise bouts at 85% HR^av for 30 
minutes. # and * denote significant differences from 
baseline for following Dex and NaCl treatment, respectively 
(p< 0.05).
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Figure 4.18. Diastolic Blood Pressure (DBP) Responses to 
Exercise Following Dexamethasone (Dex) and Saline (NaCl) 
Treatment. Baseline (BL), exercise (EX), and postexercise 
DBP response to two exercise bouts at 85% HRn,av for 30 
minutes. # and * denote significant differences from 
baseline for following Dex and NaCl treatment, respectively 
(p< 0.05).
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Figure 4.19. Mean Arterial Blood Pressure Responses to 
Exercise Following Dexamethasone (Dex) and Saline (NaCl) 
Treatment. Baseline (BL), exercise (EX), and postexercise 
MABP response to two exercise bouts at 85% HRmax for 30 
minutes. # and * denote significant differences from 
baseline for following Dex and NaCl treatment, respectively 
(p< 0.05).
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Figure 4.20. Prostaglandin E2 (PGE2 ) Responses to Exercise 
Following Dexamethasone (Dex) and Saline (NaCl) Treatment. 
Baseline (BL), exercise (EX), and postexercise PGE2 response 
to two exercise bouts at 85% HR,,,̂  for 30 minutes. # and * 
denote significant differences from baseline for following 
Dex and NaCl treatment, respectively (p< 0.05).
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Figure 4.21. Heart Rate (HR) Responses to Two Exercise Bouts 
Following Dexamethasone Treatment. Baseline (BL), exercise 
(EX), and postexercise at 85% HRn,ay for 30 minutes that were 
separated by at least two days. # and * denote significant 
differences from baseline for exercise 1 and exercise 2, 
respectively (p< 0.05).
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Figure 4.22. Systolic Blood Pressure (SBP) Responses to Two 
Exercise Bouts Following Dexamethasone Treatment. Baseline 
(BL), exercise (EX), and postexercise at 85% HR âv for 30 
minutes that were separated by at least two days. # and * 
denote significant differences from baseline for exercise 1 
and exercise 2, respectively (p< 0.05).
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Figure 4.23. Diastolic Blood Pressure (DBP) Responses to Two 
Bouts to Two Exercise Following Dexamethasone Treatment. 
Baseline (BL), exercise (EX), and postexercise DBP response 
to two exercise bouts at 85% HRn,av for 30 minutes that were 
separated by at least two days. # and * denote significant 
differences from baseline for exercise 1 and exercise 2, 
respectively (p< 0.05).
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Figure 4.24. Mean Arterial Blood Pressure (MABP) Responses 
to Two Exercise Bouts Following Dexamethasone Treatment. 
Baseline (BL), exercise (EX), and postexercise MABP response 
to two exercise bouts at 85% HR,^ for 30 minutes that were 
separated by at least two days. # and * denote significant 
differences from baseline for exercise 1 and exercise 2, 
respectively (p< 0.05).
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Figure 4.25. Prostaglandin E2 (PGE2) Responses to Two 
Exercise Bouts Following Dexamethasone Treatment. Baseline 
(BL), exercise (EX), and postexercise PGE2 response to two 
exercise bouts at 85% HRmay for 30 minutes that were 
separated by at least two days. # and * denote significant 
differences from baseline for exercise 1 and exercise 2, 
respectively (p< 0.05).
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CHAPTER 5: DISCUSSION
The purpose of this dissertation was to explore 
variables that might be related to PEH. To accomplish this, 
we compared the BP, HR, IL-1 and PGE2 responses following two 
different exercise paradigms. We then compared those same 
responses while pharmacologically blocking pathways 
hypothesized to be involved with PEH.
Experiment I
The primary objective of experiment I was to compare 
the PEH response following two different exercise paradigms. 
Although no significant BP differences were observed between 
the two levels of exercise, the higher intensity exercise 
caused a significant SBP and MABP reduction from baseline for 
one hour postexercise. The lower intensity exercise did not 
result in a significant SBP or MABP reduction. Both exercise 
intensities caused a significant HR reduction from one hour 
to three hours postexercise. IL-1 was increased immediately 
after exercise for the higher intensity exercise and at 3 
hours for the lower intensity exercise. Similar to IL-1, 
PGE2 increased immediately after both exercise bouts and at 
90 minutes postexercise of the 85% HR^ay exercise.
When the various dependent measures of BP, HR, PGE2 , and 
IL-1 were compared, most showed similar responses to 
exercise, and some differed in the overall patterns of 
response. Although both BP and HR increased during and 
decreased immediately following exercise, BP returned to 
baseline levels after about an hour whereas HR remain
75
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significantly lower than baseline. In our study only with 
the 85% HRnav- exercise did IL-1 concentrations demonstrate a 
slight relationship with PEH. Exercise produced significant 
increases in plasma concentrations of IL-1 immediately 
following (5 minutes) 85% HR^*. exercise while BP was
significantly decreased from baseline at 30 and 60 minutes 
postexercise. Plasma levels of PGE2 increased immediately 
following both exercise intensities. Therefore, this study 
supports the hypothesized existence of the PEH response in 
the dog model as well as partially supports a relationship 
between PEH and plasma concentrations of IL-1 and PGE2 in the 
dog model. However, because of IL-1 and PGE2 's differential 
pattern of response from that of PEH, more study is needed to 
more specifically assess the degree to which IL-1 is involved 
in the PEH phenomenon.
We observed a significant BP decrease following a high 
intensity exercise bout of short duration but not moderate 
intensity and of longer duration. No significant difference 
was found between the two exercise bouts which is similar to 
findings by Pescatello et al. (1991) in a group of mildly 
hypertensive men. They found that BP decreases did not 
differ between leg cycling exercise of 40% and 70% of peak 
oxygen uptake (Pescatello et al., 1991).
Although no significant blood pressure differences were 
found between our two exercise paradigms, the pattern was 
more pronounced in the higher intensity exercise bout. This 
trend concurs with the findings of Hagberg et al. (1987) in
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that the intensity of an exercise bout plays a role in the 
pattern of the PEH response.
The number of dogs within which PEH was observed may 
have contributed to the non-significant difference in BP 
observed between the 85% and 60% HRma* exercises. Four of 
the 5 dogs within the 85% HRmay exercise experienced more 
than a 10 mmHg decrease from baseline in SBP and all dogs 
experienced at least some SBP decrease from baseline 
immediately (30 minutes) following exercise. However, only 1 
of the 5 dogs within the 60% HRmav exercise experienced over 
a 10 mmHg decrease from baseline in SBP and 1 dog experienced 
a 3 mmHg increase from baseline in SBP at 30 minutes 
postexercise. The greater number of dogs that did not 
respond with SBP decreases following exercise at 60% HB^av 
along with the one dog that responded with an increase in SBP 
following exercise played a role in our trend toward a more 
pronounced PEH with higher intensity exercise.
The earlier BP and later HR postexercise reductions 
point to a possible contribution of both peripheral vascular 
resistance and cardiac output perhaps revealing a biphasic 
postexercise HR response associated with the PEH phenomenon 
within the exercise paradigm of 85% HRma* for 30 minutes.
HR increases at 30 minutes postexercise may signify a 
contribution of cardiac output, while HR decreases at 60 
minutes postexercise may point to contributions of total 
vascular resistance to the PEH response observed. These 
conclusions are supported by recent work done by Rueckert et
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al. (1996). In a group of hypertensive patients they showed 
that declines in blood pressure following exercise elicited a 
biphasic pattern: 1) an initial decrease in total or
regional vascular resistance with maintained cardiac output, 
2) followed by increasing resistance and decreased cardiac 
output. However, unlike the current experiment Reuckert et 
al. (1996) did not observe a biphasic response in HR. They 
observed a sustained tachycardic response throughout the 
entire 2 hour postexercise period. The difference in HR 
responses following dynamic exercise may be related to 
different subject populations (human versus animal subjects 
and hypertensive versus normotensive) studied by Rueckert et 
al. (1996) compared with the present study. Most of these 
conclusions are speculative, therefore, more work should be 
done to clarify the HR relationship to PEH.
IL-1 has been shown to be increased following exercise 
of moderate to high intensity (Cannon et al., 1986; and 
Lewicki et al., 1988). This was also the case in the present 
experiment. Plasma IL-l levels were increased immediately (5 
minutes) following exercise of 85% HRmax. Therefore, a 
slight relationship does exist between PEH and plasma levels 
of IL-1 following exercise although the overall pattern of 
PEH observed within the 85% HRmav exercise at 30 and 60 
minutes postexercise is not congruent with the pattern of IL- 
1 response.
Both exercise (Nowak and Wennmalm, 1978; Zambraski and 
Dunn, 1980; and Zambraski et al., 1986) and IL-1 (Warner et
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al., 1987; Libby et al., 1988; and Inoue et al., 1992) have 
been shown to induce increases in endogenous levels of PGE2 . 
Consistent with these findings, in the present study both 
plasma levels of PGE2 and IL-1 were increased immediately 
following an exercise (5 minutes) that also elicited the PEH 
(30 and 60 minutes) response. These data seem to suggest 
that both PGE2 and IL-1 are involved with the development of 
PEH. However, the time frame of significant increases in 
PGE2 and IL-1 and the occurrence of the PEH response are not 
similar. Although it is possible that the incongruent time 
of increase in IL-1 and PGE2 and the occurrence of PEH may 
simply indicate that these factors are not involved with PEH, 
this temporal difference may on the other hand reflect a 
latent activation by IL-1 of PGE2 as well as other 
vasodilatory pathways. Further, Dinarello et al. (1994) 
suggest that immune cytokines such as IL-1 can produce 
significant biologic responses within a femtomolar range. 
However, this range is not measurable by current IL-1 
bioassay methodologies. Therefore, although IL-1 
concentrations did not show significant increases during the 
time that PEH was observed, IL-1 may still have been causing 
an effect on the vasculature if not through PGE2 possibly 
through the activation of other potent vasodilators.
It may be that those increases in IL-1 levels following 
exercise (5 minutes) may be enough to activate other 
vasodilatory pathways that cause a decrease in vascular 
resistance leading to the occurrence of PEH (at 30 and 60
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minutes postexercise). Along with PGE2 , other vasodilatory 
prostanoid pathways such as prostacyclin (PGI2 ) (Rossi et 
al., 1985; and Dejana et al., 1987) as well as pathways 
leading to nitric oxide production (Kilbourn et al., 1990; 
Nathan and Stuehr, 1990; Beasley and Brenner, 1992; and Evans 
et al., 1993) are stimulated by immune system cytokines. 
More studies are needed involving the possible IL-1 
stimulated increases in vasodilatory factors associated with 
PEH.
From this study we can conclude that the PEH response 
is present in the dog model and that a higher intensity 
exercise bout produces a more pronounced PEH responses. 
However, since the duration of exercise was not studied under 
the same exercise intensity, the exact impact that duration 
may have had on BP, HR, and IL-1 responses following exercise 
remains unclear. Finally, plasma IL-1 levels are slightly 
correlated with PEH although a temporal difference does 
exist.
Experiment II
This experiment was designed to determine the effects 
of the infusion of ibuprofen or dexamethasone on BP, HR, and 
plasma PGE2 response. BP following both the infusion of 
ibuprofen as well as dexamethasone was unaffected whereas HR 
decreased significantly for almost the entire post infusion 
observation period. We also observed a trend toward a 
decrease in plasma PGE2 following ibuprofen infusion and a
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trend toward an increase in PGE2 following dexamethasone 
infusion.
An independent relationship existed between HR and BP 
as well as between PGE2 and BP in treated dogs. In spite of 
significant HR decreases following the infusion of either 
ibuprofen or dexamethasone, BP exhibited no change. 
Similarly, changes in plasma PGE2 occurred following both the 
infusion of ibuprofen and dexamethasone without effect on BP.
Our results are consistent with previous research done on 
the effects of ibuprofen on BP (McKenney et al., 1987; Wright 
et al., 1989; Pope et al., 1993). To date, it appears that 
no studies involving the acute infusion of dexamethasone with 
subsequent measurement of plasma levels of PGE2 have been 
attempted in dogs, though one study examined the blood 
pressure effects of a single 30 mg/kg intravenous dose of 
methylprednisolone in adult cats (Hall et al., 1983).
However, unlike the present study methylprednisolone 
increased both SBP and DBP in cats by approximately 50% for 
the duration of the 40 minute observation period.
Following the infusion of ibuprofen, there was an 
overall reduction in plasma levels of PGE2 , but only at 60 
minutes of the post-infusion period were plasma levels of 
PGE2 significantly reduced. It may be that a higher dose of 
ibuprofen might have been more effective in producing more 
sustained reductions in PGE2 . However, Scherkl and Frey 
(1987) noted that dogs were more sensitive to ibuprofen than 
man and that vomiting and severe gastrointestinal irritations
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occurred if given in large amounts or if chronically 
administered across days. Therefore, ibuprofen given at a 
dose of 5 mg/kg was determined to be safe in the dog.
An explanation for the effect of dexamethasone on PGE2 
may come from closer examination of individual dog responses. 
Two of the five dogs studied had similar blood pressure and 
PGE2 responses to dexamethasone infusion in that PGE2 levels 
increased without any noteworthy trends in BP. However, 
another two dogs had very different PGE2 and BP responses to 
dexamethasone treatment. For example, one dog experienced 
between a 5 mmHg to 19 mmHg decrease in MABP while also 
experiencing slight decreases in plasma levels of PGE2 . On 
the other hand, another dog showed between a 5 mmHg to 12 
mmHg increase in MABP along with a gradual increase in PGE2 
levels. The different PGE2 and BP responses of the 
individual dogs are not easily explained. It is possible that 
the three different responses (increase in PGE2 levels with 
no change in BP; increase in PGE2 levels along with an 
increase in BP; and no change in PGE2 levels in addition to a 
decrease in BP) to the same dose of dexamethasone may be due 
to the fact that the dogs that were utilized in this study 
were of mixed breed and thus a heterogenous genotype. 
However, it is also possible that a higher dose of 
dexamethasone may have produced more a congruent PGE2 and BP 
response.
In summary, HR and PGE2 responses following both 
ibuprofen and dexamethasone were independent of any changes
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in BP. BP was unaffected whereas HR decreased significantly 
for almost the entire post infusion observation period. We 
also observed a trend toward a decrease in plasma PGE2 
following ibuprofen infusion and a trend toward an increase 
in PGE2 following dexamethasone infusion while BP during both 
treatments did not change. Therefore, no relationship was 
shown to exist between HR, PGE2 , and BP after ibuprofen and 
dexamethasone infusion.
Experiment IIIA
The purpose of this experiment was to determine the 
effects of ibuprofen infusion to block COX-1 activated 
increases in plasma levels of PGE2 on BP, HR, and plasma PGE2 
levels following exercise in the dog.
The results indicate that the PEH as well as PGE2 
responses following exercise were unaffected by pretreatment 
with ibuprofen. Further, both the BP and HR response 
following exercise in this experiment seemed very similar to 
those responses of experiment I with one exception. HR 
responses after exercise in this experiment tended be to 
lower than those of experiment I. In this experiment, PGE2 
levels increased significantly 120 minutes following 
exercise, and were unaffected by ibuprofen infusion.
Like experiment I, both BP and HR increased during and 
decreased immediately following exercise. BP returned to 
baseline levels after about one hour whereas HR remain 
significantly lower than baseline levels. Plasma PGE2 
increases differ temporally (increasing at 120 to 180 minutes
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postexercise) with significant reductions in BP, which 
occurred at 30 and 60 postexercise. From these findings, 
there is no relationship between BP and PGE2 levels following 
exercise.
Although plasma PGE2 concentrations increased following 
exercise, those increases displayed an inconsistent pattern 
of response from previous reports (Nowak and Wennmalm, 1978; 
Zambraski and Dunn, 1980; Demers et al., 1981; and Zambraski 
et al., 1986). Most studies observed increased levels of
PGE2 both during and immediately after exercise. For 
example, Zambraski and Dunn (1980) in a group of 4 female 
dogs found that both plasma and urinary levels of PGE2 
increased during exercise as well as within 30 minutes of 
cessation of exercise. However, the postexercise measure of 
PGE2 was only taken once following exercise and not at 
subsequent time points of postexercise as was done in the 
current experiment.
Baseline values of plasma PGE2 measured in this 
experiment were different than those measured by Zambraski 
and Dunn (1980) . Baseline values of PGE2 in our experiment 
were approximately 500 to 700 pg/ml whereas in the Zambraski 
and Dunn (1980) study these values were about 200 pg/ml. 
Moreover, our baseline values of PGE2 are closer to those 
values obtained during and following exercise within the 
Zambraski and Dunn (1980) study. Zambraski and Dunn (1980) 
found that during and following exercise, in some of the dogs 
PGE2 values increased to about 600 to 700 pg/ml which is very
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similar to our baseline values. Therefore our baseline 
values of PGE2 may not represent true baseline levels.
These baseline differences may be explained by the 
possibility that during the baseline period of the current 
study, dogs were stressed to a point where plasma PGE2 levels 
rose above what might be considered basal levels. However, in 
the present study a 30 minute observation period took place 
before baseline measures of HR and BP were assessed. In fact, 
the criteria for adequate baseline measures of HR and BP was 
established for each dog independently and was also based 
upon previous average baseline data collected from each dog. 
It did not appear that baseline BP was out of the ordinary, 
and the dogs did not appear to be stressed. Therefore, 
although a differential basal concentrations of PGE2 in the 
present study and that of Zambraski and Dunn (1980) appear to 
exist, it does not appear that these differences point toward 
a non-basal concentration of PGE2 due to stress. Rather, 
these changes may reflect differences between assays or assay 
technique since large differences in the results of PGE2 
assays have been shown to occur (Boudreau et al., 1992).
Generally, there are two pathways by which PGE2 becomes 
activated. Cyclooxygenase 2 (COX-2) mediated increases in
PGE2 are activated by the inflammatory process with immune 
system cytokines particularly IL-1 initiating this process. 
However, ibuprofen preferentially blocks approximately 80% of 
the cyclooxygenase 1 (COX-1) mediated increases in PGE2
(Mitchell et al., 1994), and this pathway is not associated
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with the inflammatory process. In a group of dogs given E 
coli to induce the IL-1 initiated inflammatory process, 
ibuprofen has been shown to inhibit BP reductions as well as 
to lower plasma levels of PGE2 without causing changes in 
plasma levels of IL-1 (Coran et al., 1992). However, unlike 
the Coran et al. (1992) experiment, in the present experiment 
ibuprofen treatment did not cause any changes in plasma 
levels of PGE2 following exercise. Therefore, we suggest 
that perhaps the increase in PGE2 following exercise in the 
dog is not mediated by COX-1 but by the inflammatory 
associated COX-2 pathway. In other words, although ibuprofen 
may have blocked that COX-1 associated increase in PGE2 , the 
COX-2 mediated process may have continued to potentiate its 
effects on PGE2 levels after exercise. Alternatively, perhaps 
the dose of ibuprofen utilized in the present experiment 
might not have adequate to suppress COX-1 activation of PGE2 
following exercise.
We can conclude from this experiment that 1) BP and PGE2 
responses following exercise are unaffected by the infusion 
of ibuprofen at the dose evaluated, and 2) BP decreases 
observed following exercise do not appear to be related to 
plasma levels of PGE2 .
Experiment IIIB
The purpose of experiment IIIB was to evaluate the 
effect of pre-treatment with dexamethasone to block the BP, 
HR, and plasma PGE2 response following exercise.
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Dexamethasone Treatment Across Days. As stated 
previously, dexamethasone has been shown to block mRNA 
synthesis and accumulation of immune system cytokines (Han et 
al., 1990) . Dexamethasone has also been shown to
preferentially block those inflammatory pathways leading to 
the production of PGE2 . Within this inflammatory pathway, 
dexamethasone blocks cyclooxygenase-2 (COX-2) (Masferrer and 
Seibert, 1994; and Seibert and Masferrer, 1994). Therefore, 
it was hypothesized that if IL-1 mediates PEH, dexamethasone 
treatment would lead to an attenuation of the PEH response by 
way of these pathways.
In the present experiment on the first day following 
dexamethasone treatment SBP decreased significantly from 
baseline. However, SBP became significantly elevated from 
baseline on day 3 and day 4 following the initiation of 
dexamethasone treatment as well as on those days on which 
exercise was performed. SBP recovered by the first day after 
dexamethasone cessation. By day 2 of dexamethasone treatment 
HR was significantly lower than baseline and remained 
significantly decreased on both days on which exercise was 
performed. In fact, HR did not return to baseline levels 
until the third day of recovery. Plasma levels of PGE2 
significantly increased on days 2 and 3 of dexamethasone 
treatment then returned to baseline levels by the days on 
which exercise was performed.
In general, HR and SBP reacted in an opposing fashion 
to dexamethasone. After the first day of dexamethasone
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treatment, HR remained the same while SBP decreased
significantly. SBP was increasing by the second day of 
dexamethasone treatment, reaching significance on days 3 and
4. SBP was still significantly greater on the two days on 
which exercise was performed but returned slowly to baseline 
levels during the 5 days of recovery. Meanwhile, HR became 
significantly lower than baseline levels by day 2 of 
dexmethasone treatment and remained so until day 3 of 
recovery. It appears that in response to dexamethasone
treatment as well as dexamethasone cessation, changes in HR 
and SBP are inversely related to each other. Significant 
falls in HR may imply decrease contractility of the heart.
Consistent with this assumption, Nakamoto et al. (1991) 
found that elevations in blood pressure resulting from
dexamethasone administration caused significant fall in 
cardiac output and an increase in total peripheral 
resistance. They attribute increases in BP to the 
angiotensin system in which an inhibitor of angiotensin
reduced BP following dexamethasone treatment, and the 
enhanced vascular reactivity produced by norepinephrine 
administration. However, Hall et al. (1983) found that 
although methylprednisolone, a glucocorticoid, increased SBP 
by 50%, HR was not effected. Therefore, since the present 
study did not directly examine these mechanisms, the exact 
mechanism related to dexamethasone induced increases in SBP 
remain unknown.
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Plasma PGE2 and SBP appear not to be related although 
after the first day of dexamethasone treatment both seem to 
increase. However, on the days on which exercise was 
performed plasma PGE2 was back to baseline levels while on 
those same days SBP was still significantly increased from 
baseline levels. Therefore, increases in plasma levels of 
PGE2 do not appear to be associated with the increases in 
SBP.
There have been no reports of a decreased SBP following 
the first day of dexamethasone treatment or following any 
glucocorticoid treatment. Nonetheless, this SBP decrease in 
response to dexamethasone treatment was observed in the 
present study. In fact, only one study has reported BP 
responses to dexamethasone after just one day of treatment 
(Nakamoto et al., 1992). However, unlike the present study, 
Nakamoto et al. (1992) found that MABP was increased after 
the first day of dexamethasone treatment.
Whitworth et al. (1979) determined that cortisol, a 
glucocorticoid, in sheep increased MABP by approximately 10 
mmHg by day 5 of treatment. Nasjletti et al. (1984) had 
similar finding in rats given dexamethasone. They found that 
by day 14 of dexamethasone treatment SBP had increased by 
about 40 mmHg. Similarly, in the present study SBP increases 
on day 3 and 4 as well as increases on those two days on 
which exercise was performed concur with the above findings.
Unlike the Nakamoto et al. (1991) study in which a 0.5 
mg/kg/day dose of dexamethasone given to dogs caused
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significant reductions in urinary levels of PGE2 by day 3 
following dexamethasone treatment, the present study observed 
no such reductions by day 3 or 4 in plasma levels PGE2 . This 
difference can be attributed to measures of urinary versus 
plasma levels of PGE2 . For example, although Nasjletti et 
al. (1984) observed similar plasma increases in PGE2 in 
response to dexamethasone treatment as the present study, 
they also observed an increase in urinary excretion of PGE2 , 
a finding directly opposite that of Nakamoto et al. (1992).
We conclude that in response to dexamethasone treatment 
SBP first transiently decreases and then increases 
significantly over 4 days. It appears that these SBP 
increases following treatment with dexamethasone are not 
related to increases seen in plasma PGE2 since SBP was still 
elevated while PGE2 levels were decreased on the days on 
which exercise was performed.
Exercise l Following Dexamethasone Treatment vs. Saline 
Control. The purpose of this experiment was to evaluate the 
effect of dexamethasone treatment across days on the BP, HR, 
and plasma PGE2 responses to exercise.
The pattern of the blood pressure and heart rate 
response following exercise in dexamethasone treated dogs was 
very similar to that of experiment I as well as the response 
of saline treated dogs. The saline control group experienced 
the normal BP decreases following exercise which lasted for 
30 and 60 minutes postexercise. However, when treated with 
dexamethasone, the SBP response following exercise was
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attenuated from saline controls by about 60% at minute 30 and 
by greater than 25% at minute 60. Although HR was not
significantly different between the saline and dexamethasone 
treatments, a trend existed toward the HR response to 
exercise being reduced in the dexamethasone treated dogs 
compared to the saline treated dogs. Plasma levels of PGE2 
increased significantly from baseline in control dogs at 120 
to 180 minutes postexercise and also significantly increased 
at 150 to 180 minutes postexercise in dexamethasone treated 
dogs.
Following dexamethasone treatment, HR, BP, plasma PGE2 
response to exercise were attenuated but not significantly 
different from the saline control group.
Overall, these results do not support the hypothesis of 
IL-1 involvement in PEH. However, the trend toward an 
attenuation of the HR, BP, and plasma PGE2 following exercise 
after dexamethasone treatment suggests that the hypothesis of 
cytokine involvement in PEH should not be totally discounted. 
Dexamethasone has been shown to decrease mRNA synthesis of 
not only IL-1 (Knudsen et al., 1987) but also TNF alpha (Han 
et al., 1990) as well as decrease circulating levels of IL-1 
(Djaldetti et al., 1990). Using endotoxins and other 
microbial products, IL-1 mRNA transcription has been observed 
within 15 minutes (Libby et al., 1986a, 1986b). Moreover,
11-1 in vivo has a relatively short half-life, which is 
indicated by an initial fast clearance (about 3 minutes) 
followed by a second slower one (about 4 hours) (Klapproth et
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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al., 1989). With the finding of increased IL-1 activity
immediately (5 minutes) following exercise in experiment I 
along with the current experiments finding of a non­
significant dexamethasone induced attenuation of HR, BP, and 
plasma levels of PGE2 compared to saline treatment, it would 
be suggested that the IL-1 activated release of plasma PGE2 
may be involved with PEH.
For example, although not significant, plasma PGE2 
concentrations increased immediately (5 minutes) following 
exercise during saline treatment. This is a similar response 
observed with IL-1 concentrations following 85% K W *  
exercise in experiment I. Moreover, following dexamethasone 
treatment HR, BP, and plasma PGE2 levels were reduced 
compared to saline treatment although not significantly. 
Therefore, the possibility exists for a role of the immune 
system cytokine IL-1 being involved with PEH. However, since 
no significant differences were found in postexercise HR, BP, 
or plasma PGE2 levels between dexamethasone and saline 
treatments, direct evidence is lacking, and the relationship 
between IL-1 and the PEH phenomenon still remains unclear.
Based upon the results of the present study, future 
lines of research should be directed toward clearly defining 
the duration of exercise that elicits PEH. Other questions 
for future research include but should not be limited to the 
following: What role, if any, does HR play in the PEH
response? Along with PGE2, what other factors may be 
associated with IL-1 stimulated PEH response? Lastly, are
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other cytokines within the family of IL-1 (TNF and IL-6) 
involved with PEH?
Posture Effects of All Experiments
Dogs were observed, and postural data was recorded 
every minute throughout the course of all experiments. During 
the course of conducting pilot experiments, we observed 
significant changes in blood pressure due to changes in 
posture. Since the telemetry device in some dogs was placed 
on the lower left flank below heart level, hydrostatic 
pressure may have affected blood pressure measurement when 
dogs sat. In any body of water, e.g., blood, the hydrostatic 
pressure at the surface, e.g., heart, is equal to atmospheric 
pressure, but the pressure rises 1 mmHg for each 13.6mm 
distance below the surface (Guyton, 1991). Since the 
telemetry device was placed in the femoral artery located 
near the dog's flank, the distance between the heart and the 
telemetry device was estimated to be approximately 1 foot 
(304.8 mm). Therefore, the increase in blood pressure was 
approximately 22.4 mmHg.
Although standing and lying postures were recorded, 
only sitting postures were suspected of influencing blood 
pressure. A false positive PEH response may have resulted 
from the effect of posture in dogs that sat more during 
baseline period than postexercise (or postinfusion) periods 
and/or dogs that sat less during the 30 to 60 minute 
postexercise (or postinfusion) time points than during later 
time points. However, there were no significant changes in
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
the frequency of postexercise (or postinfusion) sitting from 
those of baseline within experiments I, II, IIIA, and i h b . 
Therefore, we conclude that sitting posture of dogs in this 
experiment had no significant effect on blood pressure, which 
could have produced false positive PEH responses.
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CHAPTER 6: SUMMARY AMD CONCLUSIONS
The purpose of this study was to characterize the PEH 
response following two different exercise paradigms and to 
evaluate possible mechanisms associated with PEH in the 
dog. Acute exercise has been shown to decrease blood 
pressure in humans and in animal models. Therefore, this 
study was designed to evaluate the following hypotheses: 1) 
the PEH phenomenon is present in the dog model; 2) high 
intensity exercise of short duration as compared to low 
intensity exercise of longer duration induces a greater 
blood pressure decline that lasts for a longer period of 
time; 3) immune system cytokines and their activation of 
PGE2 are associated with blood pressure reductions after 
exercise.
Results indicated that the PEH phenomenon is present 
in the dog model. Similar to normotensive humans, the dog 
demonstrates an approximate 10 mmHg SBP decline and an 
approximate 5 mmHg DBP decline that usually occurs within 
30 to 60 minutes following exercise. However, although PEH 
has been shown to occur in hypertensive animal models, we 
believe that this represents the first time that PEH has 
been demonstrated in a normotensive animal model.
Although the 85% HRmax and the 60% HRn,ax exercise 
paradigms did not reveal any significant differences 
between them, trends suggest that the exercise paradigm of 
85% HRjnax for 30 minutes produced a greater PEH response 
than the exercise paradigm of 60% HRmax f°r 60 minutes.
95
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Pharmacologic intervention studies did not reveal any 
consistent relationship between PEH and plasma 
concentrations of PGE2 and IL-1. However, the analysis 
suggested that plasma levels of IL-1 were elevated 
immediately following 85% HR,,^ exercise but were not
elevated during the time in which the PEH response occured 
(30 to 60 minutes postexercise). Nonetheless,
dexamethasone treatment caused a non-siginificant 25 to 75% 
reduction in the PEH response as well as caused a non­
significant 45%, 32%, and 34% reduction in PGE2 levels at 
5, 30, and 60 minutes postexercise, respectively. In
previous studies dexamethasone has been shown to inhibit 
cytokine activity. Therefore, IL-l's involvement in PEH 
cannot be totally discounted. Further, IL-1 activates more 
than one vasodilator, and it is possible that these factors 
may also contribute to PEH. However, based on the results 
of this study, the role of IL-1 or the immune system in the 
PEH response has not been substantiated. More study is 
needed to fully understand the exact mechanism responsible 
for PEH.
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